<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Mamm Genome</journal-id><journal-id journal-id-type="iso-abbrev">Mamm Genome</journal-id><journal-title-group><journal-title>Mammalian Genome</journal-title></journal-title-group><issn pub-type="ppub">0938-8990</issn><issn pub-type="epub">1432-1777</issn><publisher><publisher-name>Springer New York</publisher-name><publisher-loc>New York</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">17514509</article-id><article-id pub-id-type="pmc">PMC1998876</article-id><article-id pub-id-type="publisher-id">9014</article-id><article-id pub-id-type="doi">10.1007/s00335-007-9014-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Comparative genetic analysis: the utility of mouse genetic systems for studying human monogenic disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Oliver</surname><given-names>Peter L.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Bitoun</surname><given-names>Emmanuelle</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Davies</surname><given-names>Kay E.</given-names></name><address><email>kay.davies@dpag.ox.ac.uk</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.4991.5</institution-id><institution-id institution-id-type="ISNI">0000000419368948</institution-id><institution>Department of Physiology, Anatomy and Genetics, MRC Functional Genetics Unit, </institution><institution>University of Oxford, </institution></institution-wrap>South Parks Road, Oxford, OX1 3QX UK </aff></contrib-group><pub-date pub-type="epub"><day>1</day><month>7</month><year>2007</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>7</month><year>2007</year></pub-date><pub-date pub-type="ppub"><year>2007</year></pub-date><volume>18</volume><issue>6-7</issue><elocation-id>412</elocation-id><history><date date-type="received"><day>24</day><month>1</month><year>2007</year></date><date date-type="rev-recd"><day>19</day><month>3</month><year>2007</year></date><date date-type="accepted"><day>22</day><month>3</month><year>2007</year></date></history><permissions><copyright-statement>&#x000a9; Springer Science+Business Media, LLC 2007</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/2.0/</ali:license_ref><license-p>
<bold>Open Access</bold> This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (
<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/2.0/">https://creativecommons.org/licenses/by-nc/2.0</ext-link>
), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
</license-p></license></permissions><abstract id="Abs1"><p>One of the long-term goals of mutagenesis programs in the mouse has been to generate mutant lines to facilitate the functional study of every mammalian gene. With a combination of complementary genetic approaches and advances in technology, this aim is slowly becoming a reality. One of the most important features of this strategy is the ability to identify and compare a number of mutations in the same gene, an allelic series. With the advent of gene-driven screening of mutant archives, the search for a specific series of interest is now a practical option. This review focuses on the analysis of multiple mutations from chemical mutagenesis projects in a wide variety of genes and the valuable functional information that has been obtained from these studies. Although gene knockouts and transgenics will continue to be an important resource to ascertain gene function, with a significant proportion of human diseases caused by point mutations, identifying an allelic series is becoming an equally efficient route to generating clinically relevant and functionally important mouse models.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Embryonic Stem Cell</kwd><kwd>Embryonic Stem Cell Line</kwd><kwd>Splice Donor Site</kwd><kwd>Allelic Series</kwd><kwd>Embryonic Stem Cell Clone</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Science+Business Media, LLC 2007</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p>A fundamental aim of biology is not only to identify the normal function of genes but also to understand their role in human disease when mutated or otherwise abnormally affected. To this end, the mouse continues to be the model organism of choice in many cases because of extensive comparative analysis of its completed genome, the availability of an increasing number of genetic manipulation techniques, and the ability to perform physiologic and behavioral tests that can be extrapolated directly to human phenotypic traits. In addition to individual research groups examining single genes, a commitment has been made in recent years to the systematic generation of mouse mutants on a large scale using various forward genetics strategies in both whole organisms and embryonic stem (ES) cells. Despite these considerable efforts, over 70% of mammalian genes still do not have a corresponding mutant line; however, this so-called &#x0201c;phenotype gap&#x0201d; is beginning to close as these projects continue, establishing a large and valuable catalog of inherited traits, their causative mutations, and importantly, multiple alleles representing each one for comparative analysis.</p></sec><sec id="Sec2"><title>Gene knockouts and the KOMP project</title><p>One way to study gene function at the level of the whole organism is by examining the consequences of its inactivation. This may be achieved either by &#x0201c;knocking out&#x0201d; the relevant promoter or coding sequences, or by &#x0201c;knocking in&#x0201d; an inactivating point mutation, deletion, or truncation to disrupt the activity of the corresponding product. With a number of strategies available, including gene targeting by homologous, site-specific, or transpositional recombination, gene trapping, and RNA-mediated interference, knockout technology constitutes the most widely used approach to create loss-of-function alleles in model organisms (Chen and Soriano <xref ref-type="bibr" rid="CR12">2003</xref>; Kuznetsov <xref ref-type="bibr" rid="CR72">2003</xref>; Sangiuolo and Novelli <xref ref-type="bibr" rid="CR114">2004</xref>). The exploitation of inducible promoters and tissue-specific recombinase enzymes also allows the deletion of a gene of interest in a particular organ, cell type, and/or stage of development; such conditional and tissue-specific knockouts provide more accurate and finely tuned systems to study gene function than those generated by conventional constitutive technology (Porret et al. <xref ref-type="bibr" rid="CR101">2006</xref>). A combination of these approaches, in addition to the generation of multiple gene knockouts, has revolutionized the study of many fields of fundamental research, most significantly impacting developmental biology with major insights into the physiology of the hematopoietic, immune, skeletal, cardiovascular, and nervous systems (Shastry <xref ref-type="bibr" rid="CR115">1998</xref>; Sheahan et al. <xref ref-type="bibr" rid="CR116">2004</xref>; Ning et al. <xref ref-type="bibr" rid="CR92">2006</xref>).</p><p>Equally important, as technical advances in mapping and mutation screening have facilitated the rapid identification of genetic defects related to human disorders, targeted mutagenesis in the mouse has become an invaluable tool to model and gain mechanistic insights into the pathology and progression of these conditions. For example, disruption of the insulin receptor substrate-2 gene has produced a good biochemical model for type-2 diabetes (LeRoith and Gavrilova <xref ref-type="bibr" rid="CR74">2006</xref>). In addition constitutive heterozygous and conditional knockouts deficient for a variety of tumor suppressor genes faithfully recapitulate many of the clinical symptoms present in the corresponding human cancer predisposition syndromes, including <italic>Brca1</italic><sup>+/&#x02212;</sup> and <italic>Brca2</italic><sup>+/&#x02212;</sup> mice for familial breast cancer or <italic>Ptc1</italic><sup>+/&#x02212;</sup> mice for basal cell nevus syndrome (Ghebranious and Donehower <xref ref-type="bibr" rid="CR34">1998</xref>; Hakem and Mak <xref ref-type="bibr" rid="CR46">2001</xref>; Pazzaglia <xref ref-type="bibr" rid="CR99">2006</xref>). Other successes of disease modeling in the mouse from which programs of gene therapy have been initiated notably include <italic>Cftr</italic>-deficient mice for cystic fibrosis (Rosenecker et al. <xref ref-type="bibr" rid="CR107">2006</xref>; Snouwaert et al. <xref ref-type="bibr" rid="CR117">1992</xref>). These and many other knockouts have provided ideal preclinical models for diagnostic development, drug discovery, and targeted therapy testing (Walke et al. <xref ref-type="bibr" rid="CR128">2001</xref>; Zambrowicz and Sands <xref ref-type="bibr" rid="CR132">2003</xref>).</p><p>Although existing knockouts account for almost half (12,000) of the known genes in the mouse genome, only 20% have been described in the literature and/or reported in public databases such as the Mouse Knockout &#x00026; Mutation Database (<ext-link ext-link-type="uri" xlink:href="http://www.research.bmn.com/mkmd">http://www.research.bmn.com/mkmd</ext-link>) or the Mouse Genome Database (<ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org">http://www.informatics.jax.org</ext-link>). With the advent of fully annotated mouse and human genome sequences and only about 15,000 genes remaining to be disrupted, the National Institutes of Health (NIH) has recently launched the Knockout Mouse Project (KOMP), a $52 million cooperative program over five years to generate a comprehensive public resource of systematic knockout mutations of the mouse genome in ES cells by gene targeting (<ext-link ext-link-type="uri" xlink:href="http://www.nih.gov/science/models/mouse/knockout">http://www.nih.gov/science/models/mouse/knockout</ext-link>) (Austin et al. <xref ref-type="bibr" rid="CR4">2004</xref>). Each year approximately 500 new ES cell lines will be selected by a peer-review process for production of the corresponding knockout mice, reporter tissue expression analysis, and basic phenotyping. Depending on the findings, a number of those will undergo further characterization, including more detailed and specialized phenotyping and tissue profiling. Complementary high-throughput approaches have been applied to ES cell insertional mutagenesis, or gene trapping, and recent technological advances have extended the scope and value of this method to the generation of conditional knockout alleles in addition to targeted mutagenesis (Branda and Dymecki <xref ref-type="bibr" rid="CR8">2004</xref>; Cobellis et al. <xref ref-type="bibr" rid="CR15">2005</xref>). Recently, two major programs have been established, EUCOMM (<ext-link ext-link-type="uri" xlink:href="http://www.eucomm.org">http://www.eucomm.org</ext-link>) and norCOMM (<ext-link ext-link-type="uri" xlink:href="http://www.norcomm.phenogenomics.ca/index.htm">http://www.norcomm.phenogenomics.ca/index.htm</ext-link>), with the aim of generating over 30,000 new conditional gene-trap ES cell lines for analysis. In addition, these projects aim to collate and distribute compatible tissue-specific Cre recombinase lines in parallel and therefore represent a powerful resource for the selection of a desired gene knockout. By centralizing the rapid and efficient production of mouse knockouts and gene-trap lines and making them readily available to the entire scientific community, such large-scale programs will not only save considerable time and money but also will provide the basis for normalization of comparative phenotypic studies.</p><p>The seemingly perfect mouse knockout technology, however, also comes with its limitations and pitfalls. In many instances null embryos are not viable due to developmental defects, precluding the functional study of these genes at later stages of development and in the adult. This particularly applies to knockout mice of tumor suppressors which, with few exceptions, all show embryonic lethality with a distinctive pattern of organ malformations (Ghebranious and Donehower <xref ref-type="bibr" rid="CR34">1998</xref>). Although these mice have provided good models for the study of individual genes in embryonic development and the regulation of differentiation, apoptosis, and cell cycle control during organogenesis (Shastry, <xref ref-type="bibr" rid="CR115">1998</xref>), they have not necessarily been useful for the characterization of gene function in tumorigenesis. The development of conditional and tissue-specific gene-deficiency technologies mentioned above, however, has now overcome this restriction.</p><p>While mouse knockouts generally do provide very valuable information about the function of a gene <italic>in vivo</italic>, a number of reports have raised legitimate concerns as to their true value as models of human disease (Hochgeschwender and Brennan <xref ref-type="bibr" rid="CR52">1995</xref>; Routtenberg <xref ref-type="bibr" rid="CR108">1995</xref>); knockout mice often fail to recapitulate the expected clinical symptoms, sometimes producing totally unexpected, conflicting, subtle, or absent phenotypes (Elsea and Lucas <xref ref-type="bibr" rid="CR27">2002</xref>). Moreover, although most mouse genes do perform functions identical to their human homologs, the physiologic differences between these species may greatly influence the phenotypic outcome. This may notably account for differences in tissue specificity; prominent examples include <italic>p53</italic>- and <italic>Rb</italic>-deficient mice whose tumor spectrum considerably differs from that seen in patients with Li-Fraumeni and inherited childhood retinoblastoma, respectively (Ghebranious and Donehower <xref ref-type="bibr" rid="CR34">1998</xref>). Another common pitfall of gene targeting is the potential disruption of transcriptional control elements that govern the expression of neighboring genes by the introduction of a selection marker from the targeting vector. This likely explains why very different phenotypes have been obtained from the disruption of the same gene using different vectors. (Gingrich and Hen <xref ref-type="bibr" rid="CR36">2000</xref>; Olson et al. <xref ref-type="bibr" rid="CR97">1996</xref>). A number of reports have also highlighted the fact that the strategies used for gene inactivation are not equivalent. To study the role of phosphoinositide 3-kinase &#x003b3; (PI3K&#x003b3;) in cardiac function, deficient mice were generated either by using a traditional knockout strategy or by knocking in a targeted mutation that causes loss of kinase function. Surprisingly, these mice displayed different phenotypes with PI3K&#x003b3; knockout mice showing reduced inflammatory responses and increased cardiac contractility, while the mutant PI3K&#x003b3; knockin mouse retained only the immunologic defect. Molecular studies later revealed that PI3K&#x003b3; also functions as a scaffolding protein, thus transducing both kinase activity-dependent and -independent signaling pathways (Patrucco et al. <xref ref-type="bibr" rid="CR98">2004</xref>). This demonstrates that different functions of a gene may be revealed depending on the region that is inactivated.</p><p>Finally, regardless of the engineering strategy or model organism used, one major risk associated with the complete loss of function of a given gene is the establishment of compensatory mechanisms that may&#x02014;at least partially&#x02014;mask the effect of its inactivation. For example, despite the essential role of myoglobin in oxygen transport from erythrocytes to mitochondria, myoglobin knockout mice show normal cardiac function (Garry et al. <xref ref-type="bibr" rid="CR33">1998</xref>). Further studies revealed that more than half of null embryos die <italic>in utero</italic> and that those surviving have developed adaptative mechanisms to compensate for the defect in oxygen transfer (Meeson et al. <xref ref-type="bibr" rid="CR88">2001</xref>). In that respect, conditional knockout models offer another advantage over their constitutive counterparts as adaptive responses are unlikely to take place shortly after the knockout event. The lack of overt phenotype is especially frequent when the gene of interest belongs to a family of related proteins with some functional redundancy, and in many cases it may be necessary to create animals carrying null alleles of two or more members to obtain informative phenotypes (Kono et al. <xref ref-type="bibr" rid="CR71">2004</xref>).</p><p>Knockout technology has become an invaluable experimental tool for assigning gene function and modeling genetic disorders <italic>in vivo</italic>. However, it must be used with caution and some of the examples mentioned above highlight the fundamental problem posed by using genetic deficiency regarding the validity and phenotypic interpretation of knockout models; the studies are often limited to examining the compensatory effects of gene ablation as opposed to changes in the function of the gene of interest. Therefore, to address complex questions regarding gene function and regulation, complementary approaches that alter gene structure in a more subtle way must be used in conjunction with knockout technology, such as the analysis of single-point mutations and their phenotypic consequences. Such strategies may therefore be limited to the modeling of single-gene disorders as opposed to complex traits or mitochondrial or chromosomal disorders; however, approximately 10% of all human genes are currently implicated in monogenic Mendelian diseases, and this number continues to rise (Antonarakis and Beckmann <xref ref-type="bibr" rid="CR2">2006</xref>; Hamosh et al. <xref ref-type="bibr" rid="CR47">2005</xref>). Moreover, at the time of writing over two thirds of the 2300 disease genes in the Human Gene Mutation Database contain point mutations (<ext-link ext-link-type="uri" xlink:href="http://www.hgmd.cf.ac.uk/ac/index.php">http://www.hgmd.cf.ac.uk/ac/index.php</ext-link>) (Stenson et al. <xref ref-type="bibr" rid="CR119">2003</xref>). In addition, the fact that 75% of disorders in man are inherited in a dominant manner (McKusick <xref ref-type="bibr" rid="CR85">1998</xref>) indicates that both dominant and recessive mouse point mutants are vital to complement targeted knockouts and provide the most clinically relevant disease models.</p></sec><sec id="Sec3"><title>Phenotype- and genotype-driven approaches to generating allelic mouse mutants</title><p>Before the advent of molecular biology, many important discoveries were derived from mutations that arrived spontaneously in inbred mouse colonies. However, to generate significant numbers of mutant mice more efficiently, a number of large-scale <italic>N</italic>-ethyl-<italic>N</italic>-nitrosourea (ENU) mutagenesis programs were instigated ten years ago (Brown and Peters <xref ref-type="bibr" rid="CR10">1996</xref>; Hrabe de Angelis et al. <xref ref-type="bibr" rid="CR54">2000</xref>; Nolan et al. <xref ref-type="bibr" rid="CR94">2000</xref>). Their success led to the establishment of over a dozen independent centers worldwide, each with particular skills and interests and with the aim to standardize procedures and share resources (summarized in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> in Cordes <xref ref-type="bibr" rid="CR20">2005</xref>). Details of these strategies and variations in the breeding schemes have been reviewed extensively elsewhere (Brown and Balling <xref ref-type="bibr" rid="CR9">2001</xref>; Hrabe de Angelis and Balling <xref ref-type="bibr" rid="CR53">1998</xref>; Justice <xref ref-type="bibr" rid="CR64">2000</xref>). Initially, these centers have concentrated on a phenotype-driven approach, in which mutant progeny are screened for abnormalities using a simple yet quantitative assessment of physiology and behavior in combination with more focused phenotyping methods for a specific trait or organ of interest (Keays and Nolan <xref ref-type="bibr" rid="CR67">2003</xref>; Rogers et al. <xref ref-type="bibr" rid="CR106">1997</xref>; Thaung et al. <xref ref-type="bibr" rid="CR121">2002</xref>). Once inheritance of the phenotype is confimed, mutant lines of interest are then analyzed in more detail and the causative mutation is identified by positional cloning.
<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Examples of characterized allelic series (&#x0003e;3 members) generated by ENU mutagenesis</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Gene</th><th align="left">No. of sequenced ENU mutants</th><th align="left">Type of mutations</th><th align="left">References</th></tr></thead><tbody><tr><td align="left" rowspan="3">Bone morphogenic protein-5 (<italic>Bmp5</italic>)</td><td align="left" rowspan="3">11</td><td align="left">6 missense</td><td align="left" rowspan="3">Marker et al. <xref ref-type="bibr" rid="CR80">1997</xref>
</td></tr><tr><td align="left">2 nonsense</td></tr><tr><td align="left">3 splicing</td></tr><tr><td align="left" rowspan="2">Chromodomain helicase DNA-binding protein 7 (<italic>Chd7</italic>)</td><td align="left" rowspan="2">9</td><td align="left">6 nonsense</td><td align="left" rowspan="2">Kiernan et al. <xref ref-type="bibr" rid="CR70">2002</xref>; Bosman et al. <xref ref-type="bibr" rid="CR7">2005</xref>
</td></tr><tr><td align="left">3 splicing</td></tr><tr><td align="left">Type IV procollagen a1 (<italic>Col4a1</italic>)</td><td align="left">9</td><td align="left">9 missense</td><td align="left">Favor et al. <xref ref-type="bibr" rid="CR32">2007</xref>
</td></tr><tr><td align="left">Type IV procollagen a2 (<italic>Col4a2</italic>)</td><td align="left">3</td><td align="left">3 missense</td><td align="left">Favor et al. <xref ref-type="bibr" rid="CR32">2007</xref>
</td></tr><tr><td align="left" rowspan="3">Gamma-E crystallin (<italic>Cryge</italic>)</td><td align="left" rowspan="3">4</td><td align="left">2 missense</td><td align="left" rowspan="3">Graw et al. <xref ref-type="bibr" rid="CR40">2001</xref>, <xref ref-type="bibr" rid="CR41">2002</xref>, <xref ref-type="bibr" rid="CR42">2004</xref>
</td></tr><tr><td align="left">1 splicing</td></tr><tr><td align="left">1 disruption of start codon, novel protein expressed</td></tr><tr><td align="left" rowspan="2">Dystrophin (<italic>Dmd</italic>)</td><td align="left" rowspan="2">4</td><td align="left">1 nonsense</td><td align="left" rowspan="2">Im et al. <xref ref-type="bibr" rid="CR57">1996</xref>
</td></tr><tr><td align="left">3 splicing</td></tr><tr><td align="left" rowspan="2">Enamelin (<italic>Enam</italic>)</td><td align="left" rowspan="2">3</td><td align="left">2 missense</td><td align="left" rowspan="2">Masuya et al. <xref ref-type="bibr" rid="CR83">2007</xref>
</td></tr><tr><td align="left">1 splicing</td></tr><tr><td align="left" rowspan="3">Glucokinase (<italic>Gk</italic>)</td><td align="left" rowspan="3">12</td><td align="left">7 missense</td><td align="left" rowspan="3">Inoue et al. <xref ref-type="bibr" rid="CR58">2004</xref>; Toye et al. <xref ref-type="bibr" rid="CR122">2004</xref>
</td></tr><tr><td align="left">2 nonsense</td></tr><tr><td align="left">3 splicing</td></tr><tr><td align="left" rowspan="2">Glucose phosphatase isomerase (Gpi1)</td><td align="left" rowspan="2">4</td><td align="left">3 missense</td><td align="left" rowspan="2">Pearce et al. <xref ref-type="bibr" rid="CR100">1995</xref>
</td></tr><tr><td align="left">1 splicing</td></tr><tr><td align="left">G protein-coupled receptor 33 (<italic>Gpr33</italic>)</td><td align="left">5</td><td align="left">5 missense</td><td align="left">Grosse et al. <xref ref-type="bibr" rid="CR44">2006</xref>
</td></tr><tr><td align="left" rowspan="3">cGMP-phosphodiesterase 6b (<italic>Pde6b</italic>)</td><td align="left" rowspan="3">7</td><td align="left">2 missense</td><td align="left" rowspan="3">Thaung et al. <xref ref-type="bibr" rid="CR121">2002</xref>; Hart et al. <xref ref-type="bibr" rid="CR49">2005</xref>
</td></tr><tr><td align="left">3 nonsense</td></tr><tr><td align="left">2 splicing</td></tr><tr><td align="left" rowspan="2">Lactate dehydrogenase (<italic>Ldh1</italic>) </td><td align="left" rowspan="2">5</td><td align="left">4 missense</td><td align="left" rowspan="2">Sandulache et al. <xref ref-type="bibr" rid="CR113">1994</xref>; Pretsch et al. <xref ref-type="bibr" rid="CR104">1998</xref>
</td></tr><tr><td align="left">1 splicing</td></tr><tr><td align="left">Melanocortin-3 receptor (<italic>Mc3r</italic>)</td><td align="left">3</td><td align="left">3 missense</td><td align="left">Grosse et al. <xref ref-type="bibr" rid="CR44">2006</xref>
</td></tr><tr><td align="left">Malnocortin-4 receptor (<italic>Mc4r</italic>)</td><td align="left">7</td><td align="left">7 missense</td><td align="left">Grosse et al. <xref ref-type="bibr" rid="CR44">2006</xref>; Meehan et al. <xref ref-type="bibr" rid="CR87">2006</xref>
</td></tr><tr><td align="left">Mammal-fish-conserved-sequence 1 (<italic>MFSC1</italic>)</td><td align="left">3</td><td align="left">3 missense</td><td align="left">Masuya et al. <xref ref-type="bibr" rid="CR83">2007</xref>
</td></tr><tr><td align="left" rowspan="2">Myosin-Va (<italic>Myo5a</italic>)</td><td align="left" rowspan="2">10</td><td align="left">8 missense</td><td align="left" rowspan="2">Huang et al. <xref ref-type="bibr" rid="CR56">1998a</xref>, <xref ref-type="bibr" rid="CR57">1998b</xref>
</td></tr><tr><td align="left">2 splicing</td></tr><tr><td align="left" rowspan="3">Myosin-VIIa (<italic>Myo7a</italic>)</td><td align="left" rowspan="3">4</td><td align="left">1 missense</td><td align="left" rowspan="3">Mburu et al. <xref ref-type="bibr" rid="CR84">1997</xref>
</td></tr><tr><td align="left">2 nonsense</td></tr><tr><td align="left">1 splicing</td></tr><tr><td align="left" rowspan="5">Paired box gene 6 (<italic>Pax6</italic>)</td><td align="left" rowspan="5">14</td><td align="left">4 missense</td><td align="left" rowspan="5">Favor <xref ref-type="bibr" rid="CR29">1983</xref>, <xref ref-type="bibr" rid="CR30">1986</xref>; Favor and Neuhauser-Klaus <xref ref-type="bibr" rid="CR31">2000</xref>; Favor et al. <xref ref-type="bibr" rid="CR32">2001</xref>; Thaung et al. <xref ref-type="bibr" rid="CR121">2002</xref>; Graw et al. <xref ref-type="bibr" rid="CR42">2005</xref>
</td></tr><tr><td align="left">5 nonsense</td></tr><tr><td align="left">3 splice</td></tr><tr><td align="left">1 insertion</td></tr><tr><td align="left">1 disruption of Kozak sequence</td></tr><tr><td align="left" rowspan="2">Peripheral myelin protein 22 (<italic>Pmp22</italic>)</td><td align="left" rowspan="2">3</td><td align="left">2 missense</td><td align="left" rowspan="2">Isaacs et al. 2000, <xref ref-type="bibr" rid="CR61">2002</xref>
</td></tr><tr><td align="left">1 nonsense</td></tr><tr><td align="left" rowspan="2">Quaking QKI protein (<italic>Qk</italic>)</td><td align="left" rowspan="2">3 (plus 2 unknown)</td><td align="left">2 missense</td><td align="left" rowspan="2">Justice and Bode <xref ref-type="bibr" rid="CR65">1988</xref>; Noveroske et al. <xref ref-type="bibr" rid="CR95">2005</xref>
</td></tr><tr><td align="left">1 splicing</td></tr><tr><td align="left">Sodium channel Na<sub>v</sub>1.6 (<italic>Scn8a</italic>)</td><td align="left">3</td><td align="left">3 missense</td><td align="left">Buchner et al. <xref ref-type="bibr" rid="CR11">2004</xref>
</td></tr><tr><td align="left" rowspan="2">Mothers against decapentaplegic, drosophila, homolog of, 4 (<italic>Smad4</italic>)</td><td align="left" rowspan="2">4</td><td align="left">2 missense</td><td align="left" rowspan="2">Vivian et al. <xref ref-type="bibr" rid="CR127">2002</xref>; Chen et al. <xref ref-type="bibr" rid="CR14">2006</xref>
</td></tr><tr><td align="left">2 splicing</td></tr><tr><td align="left" rowspan="2">Triosephosphatase isomerase (<italic>Tpi</italic>)</td><td align="left" rowspan="2">4</td><td align="left">3 missense</td><td align="left" rowspan="2">Zingg et al. <xref ref-type="bibr" rid="CR133">1995</xref>
</td></tr><tr><td align="left">1 nonsense</td></tr></tbody></table></table-wrap>
</p><p>One advantage of this approach over targeted mutagenesis is it can create a range of mutations: hypomorphic (reduced amount of gene product), hypermorphic (increased amount of gene product), and neomorphic (altered function) alleles, in addition to those that are null (loss of function), facilitating the identification of novel functions for known genes. Such a phenomenon was recently illustrated by our own studies where the identification of a stabilizing gain-of-function point mutation in the mixed-lineage leukemia fusion partner <italic>Af4</italic>, the cause for the neurodegeneration in the ataxic mouse mutant <italic>robotic</italic>, revealed a new role for this gene in the central nervous system otherwise unpredictable from the phenotypic presentation of the <italic>Af4</italic> knockout mouse (Bitoun and Davies <xref ref-type="bibr" rid="CR5">2005</xref>; Bitoun et al. <xref ref-type="bibr" rid="CR6">2007</xref>; Isnard et al. <xref ref-type="bibr" rid="CR63">2000</xref>; Isaacs et al. <xref ref-type="bibr" rid="CR62">2003</xref>; Oliver et al. <xref ref-type="bibr" rid="CR96">2004</xref>).</p><p>The random nature of ENU also means that mutiple mutations in the same gene, an allelic series, may occur in independent lines. A combination of such mutants is therefore more likely to provide information related to gene dosage, or the identification of functionally important protein interacting domains, than a classical gene knockout. This may be particularly applicable to the pharmaceutical industry, because typically the mode of action of drugs is to alter the activity of proteins rather than eliminate their function, or to target specific residues of an active site, for example (Russ et al. <xref ref-type="bibr" rid="CR110">2002</xref>). Alternatively, a knockin of the desired mutation might provide a suitable genetic model; however, the time and cost constraints of generating one or more mutant lines using this method is often prohibitive. An engineered mutant trangene might provide a more rapid solution, although studies of transgenic lines are often confounded by factors such as epitope tags, multiple insertions, incorrect promoter artifacts, or position effects that do not influence ENU point mutations that have the advantage of always occurring at the endogneous genomic position. Consequently, an ENU mutation that is not known to be causative in human disease is still likely to provide valuable insights into gene function.</p><p>However, the practicalities of large-scale phenotype-driven mouse mutagenesis, such as the limitation and bias of the phenotyping methods, means that many potentially interesting or subtle phenotypes may simply not be detected in a first-pass screen; consequently, mutagenesis centers routinely cryopreserve tissues from each new mutant line for future rederivation and genotyping regardless of the phenotypic data obtained (Glenister and Thornton <xref ref-type="bibr" rid="CR37">2000</xref>). These resources, in combination with recent advances in the rapid detection of mutations by denaturing high-performance liquid chromatography (DHPLC) (Dobson-Stone et al. <xref ref-type="bibr" rid="CR26">2000</xref>) and temperature gradient capillary electrophoresis (TGCE) (Culiat et al. <xref ref-type="bibr" rid="CR22">2005</xref>; Sakuraba et al. <xref ref-type="bibr" rid="CR112">2005</xref>), have made it practical to use a gene-driven approach to mouse mutant detection. Here, a gene of interest can be efficiently screened for mutations by PCR from thousands of individual DNA samples followed by rederivation of the selected lines for further study (Coghill et al. <xref ref-type="bibr" rid="CR16">2002</xref>; Michaud et al. <xref ref-type="bibr" rid="CR89">2005</xref>). This technique is also applicable to ES cells that are amenable to random chemical mutagenesis and PCR screening (Chen et al. <xref ref-type="bibr" rid="CR13">2000</xref>; Munroe et al. <xref ref-type="bibr" rid="CR91">2004</xref>). Although there is no guarantee of any measureable phenotype in the resulting mutant, it has been calculated from pilot studies that 5000 DNA samples is sufficient to identify at least two alleles with 90% confidence (Coghill et al. <xref ref-type="bibr" rid="CR16">2002</xref>; Quwailid et al. <xref ref-type="bibr" rid="CR105">2004</xref>). Such values are based on estimating the proportion of the genome that is protein coding; therefore, assuming no positional bias in the mutagenic action of ENU, the larger the gene, the greater the likelihood of identifying a new mutation (Concepcion et al. <xref ref-type="bibr" rid="CR18">2004</xref>). With the size of these archives increasing and other academic centers such as RIKEN generating similar resources (Sakuraba et al. <xref ref-type="bibr" rid="CR112">2005</xref>), gene-driven screening will play an increasingly important role in the identification of multiple mutant alleles. Another, sometimes overlooked, advantage of such strategies is that all the resulting mutants from a particular ENU screen will be derived from the same genetic background, a vital feature for comparative assessment. It is well known that inbred lines differ considerably in a large number of physiologic and behavioral parameters (Contet et al. <xref ref-type="bibr" rid="CR19">2001</xref>; Kaku et al. <xref ref-type="bibr" rid="CR66">1988</xref>; Solberg et al. <xref ref-type="bibr" rid="CR118">2006</xref>), which may confound attempts to accurately compare spontaneous mutant or knockout lines on different backgrounds (Lalouette et al. <xref ref-type="bibr" rid="CR73">1998</xref>; Runkel et al. <xref ref-type="bibr" rid="CR109">2004</xref>).</p></sec><sec id="Sec4"><title>Allelic series in mouse: genotype-phenotype correlations</title><p>Historically, the first large collections of allelic series were derived from early genetic studies that analyzed the offspring of mutagenized male mice with females homozygous for a mutation that causes a visible phenotype such as coat color. These specific locus tests were not only used to titrate the effectiveness of particular mutagens accurately, but they also generated dozens of alleles at these particular loci, such as dilute and short-ear (Davis and Justice <xref ref-type="bibr" rid="CR23">1998a</xref>, <xref ref-type="bibr" rid="CR24">1998b)</xref>. There are also numerous examples of allelic spontaneous mutants, although these are, as expected, biased toward visible phenotypes such as gait dysfunction (Lalouette et al. <xref ref-type="bibr" rid="CR73">1998</xref>; Letts et al. <xref ref-type="bibr" rid="CR77">2003</xref>). There is now an increasing number of mutiple mutant alleles representing individual genes; a range of the more recent examples that have used large-scale mutagenesis are outlined in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. Although not an exhausative list, some of those that have highlighted the various experimental features of this method and have provided the most interesting functional insights are decribed below.</p><sec id="Sec5"><title><italic>Pmp22:</italic> insights into human peripheral neuropathies</title><p>The random nature of ENU as a mutagen provides a sound basis for the discovery of novel disease models; however, in a phenotype-driven screen there will naturally be a bias toward those defects that are early onset, easy to recognize, and nonlethal. Some of the earliest examples of an allelic series identified from a large-scale ENU screen are the three Trembler mutants <italic>Tr</italic><sup><italic>m1H</italic></sup>, <italic>Tr</italic><sup><italic>m2H</italic></sup>, and <italic>Tr</italic><sup><italic>m3H</italic></sup>. These dominant mutants displayed a range of resting tremor and hind-limb grasping behavior, with <italic>Tr</italic><sup><italic>m1H</italic></sup> the most severely affected and <italic>Tr</italic><sup><italic>m3H</italic></sup> the least (Isaacs et al. <xref ref-type="bibr" rid="CR60">2000</xref>, <xref ref-type="bibr" rid="CR61">2002)</xref>. Quantitative histopathologic analysis revealed that there was a direct correlation between the severity of the phenotype and the level of hypomyelination in the peripheral nerve of the mutant mice; <italic>Tr</italic><sup><italic>m1H</italic></sup> displayed the fewest and most narrowed axonal profiles and the greatest increase in endoneurial connective tissue of all the lines. The causative mutations were identified in peripheral myelin protein 22 (Pmp22), a highly conserved structural component of the axonal myelin sheath already implicated in peripheral neuropathies in humans (Isaacs et al. <xref ref-type="bibr" rid="CR60">2000</xref>, <xref ref-type="bibr" rid="CR61">2002)</xref>. The <italic>Tr</italic><sup><italic>m1H</italic></sup> mutation (H12R) is in an identical position as an amino acid substitution described in a patient suffering from Derjerine-Sottas syndrome (DSS), a severe demylelinating neuropathy (Valentijn et al. <xref ref-type="bibr" rid="CR124">1995</xref>). In addition, the Ser72 altered in the relatively mild <italic>Tr</italic><sup><italic>m3H</italic></sup> line is a putative hotspot for <italic>PMP22</italic> mutations that relate to the same disorder (Marques et al. <xref ref-type="bibr" rid="CR81">1998</xref>, <xref ref-type="bibr" rid="CR82">2004</xref>). This serine-to-threonine change is far more conservative than the four human mutations documented at the same residue in DSS patients, suggesting a strong association between genotype and phenotype. Interestingly, this can also be applied to two spontaneous Pmp22 mutants; the Pmp22-<italic>Tr</italic> mutation causes a severe tremor in mice and occurs in another conserved position altered in DSS patients (Ionasescu et al. <xref ref-type="bibr" rid="CR59">1997</xref>; Suter et al. <xref ref-type="bibr" rid="CR120">1992</xref>), whereas the less severe Charcot-Marie-Tooth disease type 1A (CMT1A) can be caused by identical mutations found in the milder <italic>Tr-J</italic> mutant (Valentijn et al. <xref ref-type="bibr" rid="CR123">1992</xref>). The <italic>Pmp22</italic> knockout also displays resting tremor and hypomyelination, although the phenotype is less severe than <italic>Tr</italic> or <italic>Tr</italic><sup><italic>m1H</italic></sup>, suggesting that the disease progression is not simply due to a loss-of-function effect (Adlkofer et al. <xref ref-type="bibr" rid="CR1">1995</xref>). Indeed, <italic>in vitro</italic> modeling experiments proposed that expression of mutant Pmp22 caused retention of wild-type protein away from the membrane (Colby et al. <xref ref-type="bibr" rid="CR17">2000</xref>). Importantly, similar experiments with the three ENU lines showed there was a direct relationship between the severity of the phenotype and the propensity of Pmp22 to form oligomers <italic>in vitro</italic> (Isaacs et al. <xref ref-type="bibr" rid="CR61">2002</xref>). The allelic series of Pmp22 mutants has therefore provided valuable insight into the genotype-phenotype correlation of peripheral neuropathies in humans.</p></sec><sec id="Sec6"><title><italic>Gk:</italic> modeling multiple human mutations in new diabetes models</title><p>Inactivating mutations in glucokinase (GK), a critical glycolysis enzyme and &#x0201c;glucose sensor&#x0201d; in insulin secreting &#x003b2; cells, are known to cause dominant maturity-onset diabetes of the young type 2 (MODY2) and recessive permanent neonatal diabetes mellitus (PNDM) (Njolstad et al. <xref ref-type="bibr" rid="CR93">2001</xref>; Vionnet et al. <xref ref-type="bibr" rid="CR125">1992</xref>). Mouse <italic>Gk</italic> knockout models have provided some insight into disease-causing mechanisms, although they have not revealed details of the structure-function relationships of this important metabolic protein (Postic et al. <xref ref-type="bibr" rid="CR102">1999</xref>). Moreover, over 190 missense, nonsense, and splicing mutations in GK have been described in MODY2 alone, suggesting that similar genetic lesions in mice would provide the most clinically relevant information (Gloyn <xref ref-type="bibr" rid="CR38">2003</xref>). Two independent groups have combined large-scale ENU mutagenesis with a biochemical screening approach to identify new mouse models of diabetes and have identified a total of 12 <italic>Gk</italic> mutations with distinct enzyme properties and hyperglycemic phenotypes (Inoue et al. <xref ref-type="bibr" rid="CR58">2004</xref>; Toye et al. <xref ref-type="bibr" rid="CR122">2004</xref>). For example, Inoue et al. demonstrated that three of their missense mutations (M-272, M-341, and M-392) caused a marked reduction in GK activity, hyperglycemia, and glucose intolerance, although only two of these (M-272 and M-341) showed a corresponding reduction in protein level, suggesting that <italic>Gk</italic> mutations can cause protein instabilty in addition to directly affecting the function of the enzyme (M-392). Another point mutation (M-210) occurred at the splice donor site of the &#x003b2;-cell-specific exon 1, causing a similar hyperglycemic phenotype and confirming that disruption of this isoform is sufficient to impair glucose regulation as observed in &#x003b2;-cell-specific <italic>Gk</italic> knockout mice (Postic et al. <xref ref-type="bibr" rid="CR102">1999</xref>). This allelic series also demonstrated that the degree of severity is significantly influenced by the position of the <italic>Gk</italic> mutation if homozygous. Severe hyperglycemia in M-210 homozygous mutant pups was first detectable at postnatal day 2 (P2), in addition to marked growth retardation, liver abnormalities, and eventual death by P7. By contrast, the M-392 point mutation produced a milder hyperglycemic phenotype when homozygous, with no overt growth retardation or liver defects (Inoue et al. <xref ref-type="bibr" rid="CR58">2004</xref>). The differing phenotypes are related to the relative position of the mutations; M-210 homozygous mice have a phenotype similar to <italic>Gk</italic> knockouts, whereas the M-392 mutation occurs in the glucose-binding region as opposed to the more functionally significant catalytic domain (Gidh-Jain et al. <xref ref-type="bibr" rid="CR35">1993</xref>). Importantly, four of the newly identified <italic>Gk</italic> mutations, including the &#x003b2;-cell-specific substiution, are identical to those found in humans (Gloyn <xref ref-type="bibr" rid="CR38">2003</xref>); the missense mutation (M-236) at Thr288 is not only identical to mutations found in both MODY2 and PNDM patients, but it is situated in the active site of GK, correlating directly with the reported significant reduction in kinase activity of the enzyme (Davis et al. <xref ref-type="bibr" rid="CR25">1999</xref>; Gidh-Jain et al. <xref ref-type="bibr" rid="CR35">1993</xref>). These new mutants have provided a detailed structure-function study of GK and the relationship between varying levels of its inactivation to hyperglycemic phenotypes that are directly relevant to both dominant and recessive forms of diabetes.</p></sec><sec id="Sec7"><title><italic>Quaking:</italic> functional analysis of protein isoforms</title><p>The RNA binding protein encoded by the <italic>quaking</italic> loci mediates the stabilty and splicing of oligodendrocyte RNA transcripts such as myelin basic protein (MBP) and exists in three distinct isforms: QKI-5, -6, and -7 (Wu et al. <xref ref-type="bibr" rid="CR131">2002</xref>). A total of five ENU-induced mutants have since been identified by their failure to complement the original spontaneous <italic>qk</italic><sup><italic>v</italic></sup><italic>/qk</italic><sup><italic>v</italic></sup> line: four that are homozygous embryonic lethal (<italic>qk</italic><sup><italic>kt1m</italic></sup>, <italic>qk</italic><sup><italic>k2</italic></sup>, <italic>qk</italic><sup><italic>kt3/4</italic></sup>, and <italic>qk</italic><sup><italic>l-1</italic></sup>) and a single viable allele (<italic>qk</italic><sup><italic>e5</italic></sup>) that causes seizures in the second postnatal week in addition to adult-onset progressive ataxia (Justice and Bode <xref ref-type="bibr" rid="CR65">1988</xref>; Noveroske et al. <xref ref-type="bibr" rid="CR95">2005</xref>). In addition to demonstrating an unexpected developmental role for this gene, subtle yet significant differences in the embryonic phenotypes of the four lethal lines have revealed new information regarding the functional domains of the QKI isoforms. For example, the <italic>qk</italic><sup><italic>k2</italic></sup> mutation causes death at embryonic day (E) 8.5-11.5 due to a disorganization of the anterior-posterior (A-P) axis, in addition to cranial and heart defects (Justice and Bode <xref ref-type="bibr" rid="CR65">1988</xref>). The causative mutation appears to be inherited in a semidominant manner and occurs at a highly conserved amino acid in the RNA-binding (KH) domain common to all three QKI isoforms (Cox et al. <xref ref-type="bibr" rid="CR21">1999</xref>). In contrast, a splice site is disrupted in the recessive <italic>qk</italic><sup><italic>l-1</italic></sup> mutant, leading to a loss of the QKI-5 protein and cessation of development between E8.0 and E9.0, suggesting that disruption of the nuclear isoform is sufficient to cause embryonic lethality (Cox et al. <xref ref-type="bibr" rid="CR21">1999</xref>; Justice and Bode <xref ref-type="bibr" rid="CR65">1988</xref>). Despite the viability of <italic>qk</italic><sup><italic>e5</italic></sup><italic>/qk</italic><sup><italic>e5</italic></sup> mice, severe dysmyelination of the brain is evident, in addition to the presence of axonal swellings in the cerebellum that are likely to account for the observed ataxia. Expression studies revealed that the QKI-6 and -7 isoforms are not present in mutant postnatal oligodendrocytes and levels of QKI-5 are considerably reduced, although all three isoforms appear to be expressed at normal levels in astrocytes (Noveroske et al. <xref ref-type="bibr" rid="CR95">2005</xref>). Because no coding mutations in the <italic>quaking</italic> loci were identified, this evidence points to disruption of an as-yet unidentified tissue-specific regulatory region. Further examination showed that markers of mature oligodendrocytes were disrupted in <italic>qk</italic><sup><italic>e5</italic></sup><italic>/qk</italic><sup><italic>e5</italic></sup> mice, suggesting that the severe phenotype is due to defective myelination by QKI-regulated pathways rather than to aberant development of these cells during proliferation. The biological importance of the <italic>qk</italic><sup><italic>e5</italic></sup> mutant is also emphasized by the fact that the original viable <italic>qk</italic><sup><italic>v</italic></sup> line contains a large deletion that disrupts two additional genes that are likely to influence the demyelination phenotype (Lorenzetti et al. <xref ref-type="bibr" rid="CR78">2004</xref>). This ENU-derived allelic series has not only revealed a new role for <italic>quaking</italic> in embryonic vasculogenesis, but it has also demonstrated that regulation of the gene is critical for normal CNS myelination; these mutants are a useful resource for modeling seizure and neural tube defects in addition to psychiatric disorders such as schizophrenia to which human QKI has recently been associated (Haroutunian et al. <xref ref-type="bibr" rid="CR48">2006</xref>).</p></sec><sec id="Sec8"><title><italic>Pde6b:</italic> new models of retinal degeneration</title><p>From a phenotype-driven screen of over 6000 ENU mutants for vision defects detectable by either microscopy or visual tracking response, 25 inherited phenotypes were isolated, with 7 of these caused by mutations in <italic>Pde6b</italic>, a gene previously implicated in eye pathophysiology (Thaung et al. <xref ref-type="bibr" rid="CR121">2002</xref>). Mutations in the &#x003b2; subunit of the rod cGMP-phosphodiesterase (<italic>PDE6B</italic>) gene have been shown to account for approximately 2% of cases of retinitis pigmentosa (RP), causing degeneration of the retina and blindness (McLaughlin et al. <xref ref-type="bibr" rid="CR86">1995</xref>). Mice homozygous for the null Pde6b allele (<italic>Pde6b</italic><sup><italic>rd1</italic></sup>) provide a model for autosomal recessive (ar) RP, but suffer from almost complete photoreceptor apoptotic degeneration by three weeks of age due to persistent opening of cGMP-gated cation channels (Chang et al. 1993). Consequently, a <italic>Pde6b</italic> allelic series containing mutants with slower disease onset would be more practical as a tool for analyzing potential therapeutic strategies. Four of the novel recessive mutants identified (<italic>Pde6b</italic><sup><italic>rd1-1-4H</italic></sup>) displayed essentially identical phenotypes to the endogenous <italic>Pde6b</italic><sup><italic>rd1</italic></sup> alleles of the C3H mouse strain; however, the remaining lines showed varying degrees of post-weaning-onset atypical retinal degeneration (atrd), named <italic>Pde6b</italic><sup><italic>atrd1-3</italic></sup> (Hart et al. <xref ref-type="bibr" rid="CR49">2005</xref>; Thaung et al. <xref ref-type="bibr" rid="CR121">2002</xref>). As expected from their related pathology to <italic>Pde6b</italic><sup><italic>rd1</italic></sup> mice, the four <italic>Pde6b</italic><sup><italic>1-4H</italic></sup> mutants contained mutations that are predicted to cause loss of function: three generated premature stop codons and the fourth altered a highly conserved splice donor site. Interestingly, the latter mutation is identical to one found in a patient with arRP, once again correlating ENU mutants with aberant human alleles (McLaughlin et al. <xref ref-type="bibr" rid="CR86">1995</xref>). Of the three less severe alleles, two mutations (<italic>Pde6b</italic><sup><italic>atrd1</italic></sup> and <italic>Pde6b</italic><sup><italic>atrd3</italic></sup>) were in the catalytic domain of Pde6b and the third (<italic>Pde6b</italic><sup><italic>atrd2</italic></sup>) occurred in another splice donor site. Molecular analysis of <italic>Pde6b</italic><sup><italic>atrd2</italic></sup> transcripts showed that the predominant product was truncated and presumably nonfunctional, although 17% of the transcripts analyzed were correctly spliced and expressed, presumably accounting for the milder retinal degeneration seen in this mutant line compared to <italic>rd1</italic> mice (Hart et al. <xref ref-type="bibr" rid="CR49">2005</xref>). Combined visual acuity, fundus, and histopathologic analysis of the three atrd lines showed that <italic>Pde6b</italic><sup><italic>atrd1</italic></sup> displays the least severe phenotype; this may reflect the fact that in related phosphodiesterases the mutated histidine is replaced by a tyrosine, indicating that this residue is not necessarily functionally essential. By contrast, the asparagine mutated in <italic>Pde6b</italic><sup><italic>atrd3</italic></sup> mice is conserved in all known mammalian phosphodiesterases, and this is reflected in a reduced visual acuity performance compared with those homozygous for the <italic>Pde6b</italic><sup><italic>atrd1</italic></sup> allele (Hart et al. <xref ref-type="bibr" rid="CR49">2005</xref>). The strong genotype-phenotype correlation in this study has shed new light on the functional domains of Pde6b as well as provide valuable new models for RP and related disorders.</p></sec><sec id="Sec9"><title><italic>Smad4:</italic> ES cell-derived gene-driven screening</title><p>Whereas gene-driven screens from whole-animal archives have proved to be successful, the initial cost and space involved in generating thousands of lines may be prohibitive (Williams et al. <xref ref-type="bibr" rid="CR130">2003</xref>). Consequently, a number of groups have established mutagenized ES cell libraries for PCR screening and subsequent recovery (Chen et al. <xref ref-type="bibr" rid="CR13">2000</xref>; Munroe et al. <xref ref-type="bibr" rid="CR91">2004</xref>). The validity of this approach has been demonstrated by the identification of 29 <italic>Smad2</italic> and <italic>Smad4</italic> mutations in a screen of over 2000 ENU-mutagenized ES cell clones (Vivian et al. <xref ref-type="bibr" rid="CR127">2002</xref>). Both genes, transducers of transforming growth factor &#x003b2; (TGF-&#x003b2;) superfamily signaling, have been implicated in the development of human cancers (Miyaki and Kuroki <xref ref-type="bibr" rid="CR90">2003</xref>), although the perigastrulation lethality of knockouts has limited research into their role in late embryonic stages or adult life (Weinstein et al. <xref ref-type="bibr" rid="CR129">2000</xref>). A series of <italic>Smad4</italic> mutants was recovered and, unexpectedly, three of these lines, <italic>Smad</italic><sup><italic>m1Mag</italic></sup>, <italic>Smad</italic><sup><italic>m2Mag</italic></sup>, and <italic>Smad</italic><sup><italic>m3Mag</italic></sup>, were viable in the homozygous state and displayed no detectable phenotype in adults despite missense substitutions in three conserved residues spread throughout the protein. The <italic>Smad4</italic><sup><italic>m4Mag</italic></sup> mutation, however, occurred in a splice donor site, causing the deletion of an exon and the generation of a truncated protein with 19 additional out-of-frame amino acids. Homozygous <italic>Smad4</italic><sup><italic>m4Mag</italic></sup> mutants, unsurprisingly, did not survive embryogenesis and failed to initiate gastrulation. Interestingly, ES cells heterozygous for the mutation showed steady-state Smad4 protein levels considerably lower than expected, suggesting that the mutant protein may confer instability to wild-type Smad4 (Vivian et al. <xref ref-type="bibr" rid="CR127">2002</xref>). This was confirmed by further biochemical analysis that demonstrated that the truncated protein is not only targeted for proteosomal degradation but can form a complex with wild-type Smad4, targeting it for proteolysis (Chen et al. <xref ref-type="bibr" rid="CR14">2006</xref>). This pilot study illustrates that although an ES-cell gene-driven approach can be used to generate allelic series, because of the random nature of the mutagen not all new lines may have a functional effect on the gene of interest.</p></sec><sec id="Sec10"><title>The MFCS1 element: mutation analysis of a regulatory region</title><p>While the vast majority of gene-driven screens have concentrated on exonic and splice site regions, the method can equally be applied to any genomic sequence. A recent study has screened a short, well-characterized cis-acting element, Mammal-fish-conserved-sequence 1 (MFCS1), which regulates the expression of the polarity-signaling protein Sonic hedgehog (Shh) (Masuya et al. <xref ref-type="bibr" rid="CR83">2007</xref>). In humans there are a number of cases of preaxial polydactyly (PPD) caused by point mutations in MFCS1 (Lettice et al. <xref ref-type="bibr" rid="CR76">2003</xref>; Maas and Fallon <xref ref-type="bibr" rid="CR79">2005</xref>); however, no molecular motifs have been discovered in this region that explain the mechanisms involved in <italic>Shh</italic> regulation by an element situated over 1 Mb upstream of the coding region (Lettice et al. <xref ref-type="bibr" rid="CR75">2002</xref>). From over 3500 mutant mice screened, three new mutations were discovered, <italic>M101116</italic>, <italic>M101117</italic>, and <italic>M101192</italic>, flanking the pre-existing PPD ENU mutant <italic>M100081</italic> (Sagai et al. <xref ref-type="bibr" rid="CR111">2004</xref>). <italic>M101117</italic> and <italic>M101192</italic> showed no limb dismorphology, whereas the remaining lines had a semidominant PPD phenotype, with <italic>M100081</italic> also showing tibial hemimelia when in the homozygous state. Ectopic expression of <italic>Shh</italic> was detected in the anterior region of the hind-limb bud of <italic>M100081</italic> and <italic>M101116</italic> homozygotes at E10.5, which was confirmed by transgenic analysis of embryos generated with the <italic>LacZ</italic> reporter gene under the control of mutated MFCS1. As expected, the level of ectopic <italic>Shh</italic> expression correlated with the relative severity of the PDD phenotype, but also with the evolutionary conservation of the mutated nucleotide; the <italic>M100081</italic> and <italic>M101116</italic> substitutions occur at positions found in <italic>fugu</italic>, whereas the nucleotide positions altered in the less severe <italic>M10117</italic> and <italic>M101192</italic> lines are conserved only as far as chicken. The molecular mechanisms controlling these observations remain unclear and may relate to aberrant binding of transcription factors. However, this study highlights the power of this strategy to identify novel features of regulatory elements, a natural progression from the current mutation analysis of protein-coding domains.</p></sec></sec><sec id="Sec11"><title>Conclusions and future prospects</title><p>The cost of generating a new allelic series is continually decreasing with advances in DNA analysis and the expansion of mutant mouse archives. For example, combining TGCE with over 17,000 mutant genomic DNA samples, Ingenium Pharmaceuticals state they are able to generate at least five new alleles for any given gene and provide live adult mutant mice within three to four months (Augustin et al. <xref ref-type="bibr" rid="CR3">2005</xref>). With this number of novel strains available, preselection of the most biologically relevant mutations will become routine and necessary in many cases (Grosse et al. <xref ref-type="bibr" rid="CR44">2006</xref>). Improvements in ES cell technology have also enhanced the efficiency of gene-driven screens from mutagenized stem cell archives. Recovery of these lines has traditionally relied on introducing ES cells into blastocycts, followed by two rounds of breeding to generate mice homozygous for the desired mutation. Hybrid ES cell lines and tetraploid host embryos can facilitate the identification of phenotypes in the first generation (F<sub>0</sub>), although this method suffers from a number of confounding technical inefficiencies that preclude its use as a high-throughput strategy. The latest advance uses laser-assisted injection of ES cells into eight-cell-stage embryos, generating viable F<sub>0</sub> mice of both sexes that are nearly 100% chimeric. A pilot study demonstrated that the phenotype of previously characterized mutations could be successfully recapitulated in mice recovered from ES cells using this method (Poueymirou et al. <xref ref-type="bibr" rid="CR103">2007</xref>). It has even been possible to identify and successfully rederive new splice variants from a highly pooled archive of 40,000 mutagenized ES cell clones using nested exon-skipping PCR primers (Greber et al. <xref ref-type="bibr" rid="CR43">2005</xref>). Because the time and cost of these high-thoughput technologies is decreasing, the availability of an &#x0201c;off-the-shelf&#x0201d; series of mutations for a given gene is slowly becoming a reality.</p><p>It must not be overlooked, however, that each new ENU mutant line harbors many other mutations in addition to the one that may have been identified by gene-driven screening (Hitotsumachi et al. <xref ref-type="bibr" rid="CR51">1985</xref>). The estimate that one functional animo acid change is obtained every 1.82 Mb of coding DNA was determined from a gene-based screen of the Harwell ENU archive (Quwailid et al. <xref ref-type="bibr" rid="CR105">2004</xref>). Consequently it was calculated that there is still a 7% chance that a second confounding mutation is linked to the originally identified loci after ten generations of backcrossing to a wild-type strain (Keays et al. <xref ref-type="bibr" rid="CR68">2006</xref>). Marker-assisted selection (MAS), in which offspring with the smallest amount of donor chromosome linked to the mutation of interest are used for breeding, can be used to circumvent this problem (Visscher et al. <xref ref-type="bibr" rid="CR126">1996</xref>). Although this may detract from the apparent speed and convenience of a gene-driven approach, additional experimental evidence such as a BAC rescue (Keays et al. <xref ref-type="bibr" rid="CR69">2007</xref>) or even a second allelic mutation (Hafezparast et al. <xref ref-type="bibr" rid="CR45">2003</xref>) can provide sufficient supporting evidence that a novel genetic lesion is causative.</p><p>As the studies above have illustrated, multiple-mutant alleles frequently provide valuable insight into gene function, including unexpected and serendipitous findings, as a consequence of the random nature of ENU mutagenesis. The power of this technique relies on evolutionary conservation of DNA sequence and physiologic parameters to extrapolate conclusions to human disease states; consequently, the mouse will continue to provide important and clinically relevant phenotypes. Moreover, there is likely to be a move toward mutation screening of non-protein-coding regions such as promoter elements, introns, and noncoding RNAs as more is learned about their role in biology. For example, the modeling of human point mutations in the noncoding RMRP RNA has provided new insight into the role of this component of the ribonucleoprotein complex in cartilage-hair hypoplasia (Hermanns et al. <xref ref-type="bibr" rid="CR50">2005</xref>). There is no doubt, therefore, that large-scale chemical mutagenesis, in combination with other genetic tools such as conventional and conditional knockouts, knockins, and transgenics will continue to play a vital role in the generation of new therapeutic targets.</p></sec></body><back><ref-list id="Bib1"><title>References</title><ref id="CR1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adlkofer</surname><given-names>K</given-names></name><name><surname>Martini</surname><given-names>R</given-names></name><name><surname>Aguzzi</surname><given-names>A</given-names></name><name><surname>Zielasek</surname><given-names>J</given-names></name><name><surname>Toyka</surname><given-names>KV</given-names></name><etal/></person-group><article-title>Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice</article-title><source>Nat Genet</source><year>1995</year><volume>11</volume><fpage>274</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">7581450</pub-id></element-citation></ref><ref id="CR2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonarakis</surname><given-names>SE</given-names></name><name><surname>Beckmann</surname><given-names>JS</given-names></name></person-group><article-title>Mendelian disorders deserve more attention</article-title><source>Nat Rev Genet</source><year>2006</year><volume>7</volume><fpage>277</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">16534515</pub-id></element-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Augustin</surname><given-names>M</given-names></name><name><surname>Sedlmeier</surname><given-names>R</given-names></name><name><surname>Peters</surname><given-names>T</given-names></name><name><surname>Huffstadt</surname><given-names>U</given-names></name><name><surname>Kochmann</surname><given-names>E</given-names></name><etal/></person-group><article-title>Efficient and fast targeted production of murine models based on ENU mutagenesis</article-title><source>Mamm Genome</source><year>2005</year><volume>16</volume><fpage>405</fpage><lpage>413</lpage><pub-id pub-id-type="pmid">16075367</pub-id></element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Austin</surname><given-names>CP</given-names></name><name><surname>Battey</surname><given-names>JF</given-names></name><name><surname>Bradley</surname><given-names>A</given-names></name><name><surname>Bucan</surname><given-names>M</given-names></name><name><surname>Capecchi</surname><given-names>M</given-names></name><etal/></person-group><article-title>The knockout mouse project</article-title><source>Nat Genet</source><year>2004</year><volume>36</volume><fpage>921</fpage><lpage>924</lpage><pub-id pub-id-type="pmid">15340423</pub-id></element-citation></ref><ref id="CR5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bitoun</surname><given-names>E</given-names></name><name><surname>Davies</surname><given-names>KE</given-names></name></person-group><article-title>The robotic mouse: unravelling the function of AF4 in the cerebellum</article-title><source>Cerebellum</source><year>2005</year><volume>4</volume><fpage>1</fpage><lpage>11</lpage></element-citation></ref><ref id="CR6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bitoun</surname><given-names>E</given-names></name><name><surname>Oliver</surname><given-names>PL</given-names></name><name><surname>Davies</surname><given-names>KE</given-names></name></person-group><article-title>The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling</article-title><source>Hum Mol Genet</source><year>2007</year><volume>16</volume><fpage>92</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">17135274</pub-id></element-citation></ref><ref id="CR7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosman</surname><given-names>EA</given-names></name><name><surname>Penn</surname><given-names>AC</given-names></name><name><surname>Ambrose</surname><given-names>JC</given-names></name><name><surname>Kettleborough</surname><given-names>R</given-names></name><name><surname>Stemple</surname><given-names>DL</given-names></name><etal/></person-group><article-title>Multiple mutations in mouse Chd7 provide models for CHARGE syndrome</article-title><source>Hum Mol Genet</source><year>2005</year><volume>14</volume><fpage>3463</fpage><lpage>3476</lpage><pub-id pub-id-type="pmid">16207732</pub-id></element-citation></ref><ref id="CR8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Branda</surname><given-names>CS</given-names></name><name><surname>Dymecki</surname><given-names>SM</given-names></name></person-group><article-title>Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice</article-title><source>Dev Cell</source><year>2004</year><volume>6</volume><fpage>7</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">14723844</pub-id></element-citation></ref><ref id="CR9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>SD</given-names></name><name><surname>Balling</surname><given-names>R</given-names></name></person-group><article-title>Systematic approaches to mouse mutagenesis</article-title><source>Curr Opin Genet Dev</source><year>2001</year><volume>11</volume><fpage>268</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">11377962</pub-id></element-citation></ref><ref id="CR10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>SD</given-names></name><name><surname>Peters</surname><given-names>J</given-names></name></person-group><article-title>Combining mutagenesis and genomics in the mouse&#x02014;closing the phenotype gap</article-title><source>Trends Genet</source><year>1996</year><volume>12</volume><fpage>433</fpage><lpage>435</lpage><pub-id pub-id-type="pmid">8973140</pub-id></element-citation></ref><ref id="CR11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buchner</surname><given-names>DA</given-names></name><name><surname>Seburn</surname><given-names>KL</given-names></name><name><surname>Frankel</surname><given-names>WN</given-names></name><name><surname>Meisler</surname><given-names>MH</given-names></name></person-group><article-title>Three ENU-induced neurological mutations in the pore loop of sodium channel Scn8a (Na(v)1.6) and a genetically linked retinal mutation, rd13</article-title><source>Mamm Genome</source><year>2004</year><volume>15</volume><fpage>344</fpage><lpage>351</lpage><pub-id pub-id-type="pmid">15170223</pub-id></element-citation></ref><ref id="CR12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>GQ</given-names></name><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Wong</surname><given-names>F</given-names></name></person-group><article-title>Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice</article-title><source>Neuron</source><year>1993</year><volume>11</volume><fpage>595</fpage><lpage>605</lpage><pub-id pub-id-type="pmid">8398150</pub-id></element-citation></ref><ref id="CR13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>WV</given-names></name><name><surname>Soriano</surname><given-names>P</given-names></name></person-group><article-title>Gene trap mutagenesis in embryonic stem cells</article-title><source>Methods Enzymol</source><year>2003</year><volume>365</volume><fpage>367</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">14696359</pub-id></element-citation></ref><ref id="CR14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yee</surname><given-names>D</given-names></name><name><surname>Dains</surname><given-names>K</given-names></name><name><surname>Chatterjee</surname><given-names>A</given-names></name><name><surname>Cavalcoli</surname><given-names>J</given-names></name><etal/></person-group><article-title>Genotype-based screen for ENU-induced mutations in mouse embryonic stem cells</article-title><source>Nat Genet</source><year>2000</year><volume>24</volume><fpage>314</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">10700191</pub-id></element-citation></ref><ref id="CR15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yee</surname><given-names>D</given-names></name><name><surname>Magnuson</surname><given-names>T</given-names></name></person-group><article-title>A novel mouse Smad4 mutation reduces protein stability and wild-type protein levels</article-title><source>Mamm Genome</source><year>2006</year><volume>17</volume><fpage>211</fpage><lpage>219</lpage><pub-id pub-id-type="pmid">16518688</pub-id></element-citation></ref><ref id="CR16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cobellis</surname><given-names>G</given-names></name><name><surname>Nicolaus</surname><given-names>G</given-names></name><name><surname>Iovino</surname><given-names>M</given-names></name><name><surname>Romito</surname><given-names>A</given-names></name><name><surname>Marra</surname><given-names>E</given-names></name><etal/></person-group><article-title>Tagging genes with cassette-exchange sites</article-title><source>Nucleic Acids Res</source><year>2005</year><volume>33</volume><fpage>e44</fpage><pub-id pub-id-type="pmid">15741177</pub-id></element-citation></ref><ref id="CR17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coghill</surname><given-names>EL</given-names></name><name><surname>Hugill</surname><given-names>A</given-names></name><name><surname>Parkinson</surname><given-names>N</given-names></name><name><surname>Davison</surname><given-names>C</given-names></name><name><surname>Glenister</surname><given-names>P</given-names></name><etal/></person-group><article-title>A gene-driven approach to the identification of ENU mutants in the mouse</article-title><source>Nat Genet</source><year>2002</year><volume>30</volume><fpage>255</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">11850622</pub-id></element-citation></ref><ref id="CR18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colby</surname><given-names>J</given-names></name><name><surname>Nicholson</surname><given-names>R</given-names></name><name><surname>Dickson</surname><given-names>KM</given-names></name><name><surname>Orfali</surname><given-names>W</given-names></name><name><surname>Naef</surname><given-names>R</given-names></name><etal/></person-group><article-title>PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells</article-title><source>Neurobiol Dis</source><year>2000</year><volume>7</volume><fpage>561</fpage><lpage>573</lpage><pub-id pub-id-type="pmid">11114256</pub-id></element-citation></ref><ref id="CR19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Concepcion</surname><given-names>D</given-names></name><name><surname>Seburn</surname><given-names>KL</given-names></name><name><surname>Wen</surname><given-names>G</given-names></name><name><surname>Frankel</surname><given-names>WN</given-names></name><name><surname>Hamilton</surname><given-names>BA</given-names></name></person-group><article-title>Mutation rate and predicted phenotypic target sizes in ethylnitrosourea-treated mice</article-title><source>Genetics</source><year>2004</year><volume>168</volume><fpage>953</fpage><lpage>959</lpage><pub-id pub-id-type="pmid">15514066</pub-id></element-citation></ref><ref id="CR20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contet</surname><given-names>C</given-names></name><name><surname>Rawlins</surname><given-names>JN</given-names></name><name><surname>Deacon</surname><given-names>RM</given-names></name></person-group><article-title>A comparison of 129S2/SvHsd and C57BL/6JOlaHsd mice on a test battery assessing sensorimotor, affective and cognitive behaviours: implications for the study of genetically modified mice</article-title><source>Behav Brain Res</source><year>2001</year><volume>124</volume><fpage>33</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">11423164</pub-id></element-citation></ref><ref id="CR21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cordes</surname><given-names>SP</given-names></name></person-group><article-title>N-ethyl-N-nitrosourea mutagenesis: boarding the mouse mutant express</article-title><source>Microbiol Mol Biol Rev</source><year>2005</year><volume>69</volume><fpage>426</fpage><lpage>439</lpage><pub-id pub-id-type="pmid">16148305</pub-id></element-citation></ref><ref id="CR22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>RD</given-names></name><name><surname>Hugill</surname><given-names>A</given-names></name><name><surname>Shedlovsky</surname><given-names>A</given-names></name><name><surname>Noveroske</surname><given-names>JK</given-names></name><name><surname>Best</surname><given-names>S</given-names></name><etal/></person-group><article-title>Contrasting effects of ENU induced embryonic lethal mutations of the quaking gene</article-title><source>Genomics</source><year>1999</year><volume>57</volume><fpage>333</fpage><lpage>341</lpage><pub-id pub-id-type="pmid">10328999</pub-id></element-citation></ref><ref id="CR23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Culiat</surname><given-names>CT</given-names></name><name><surname>Klebig</surname><given-names>ML</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Monroe</surname><given-names>H</given-names></name><name><surname>Stanford</surname><given-names>B</given-names></name><etal/></person-group><article-title>Identification of mutations from phenotype-driven ENU mutagenesis in mouse chromosome 7</article-title><source>Mamm Genome</source><year>2005</year><volume>16</volume><fpage>555</fpage><lpage>566</lpage><pub-id pub-id-type="pmid">16180137</pub-id></element-citation></ref><ref id="CR24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>AP</given-names></name><name><surname>Justice</surname><given-names>MJ</given-names></name></person-group><article-title>Mouse alleles: if you&#x02019;ve seen one, you haven&#x02019;t seen them all</article-title><source>Trends Genet</source><year>1998</year><volume>14</volume><fpage>438</fpage><lpage>441</lpage><pub-id pub-id-type="pmid">9825669</pub-id></element-citation></ref><ref id="CR25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>AP</given-names></name><name><surname>Justice</surname><given-names>MJ</given-names></name></person-group><article-title>An Oak Ridge legacy: the specific locus test and its role in mouse mutagenesis</article-title><source>Genetics</source><year>1998</year><volume>148</volume><fpage>7</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">9475716</pub-id></element-citation></ref><ref id="CR26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>EA</given-names></name><name><surname>Cuesta-Munoz</surname><given-names>A</given-names></name><name><surname>Raoul</surname><given-names>M</given-names></name><name><surname>Buettger</surname><given-names>C</given-names></name><name><surname>Sweet</surname><given-names>I</given-names></name><etal/></person-group><article-title>Mutants of glucokinase cause hypoglycaemia and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis</article-title><source>Diabetologia</source><year>1999</year><volume>42</volume><fpage>1175</fpage><lpage>1186</lpage><pub-id pub-id-type="pmid">10525657</pub-id></element-citation></ref><ref id="CR27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobson-Stone</surname><given-names>C</given-names></name><name><surname>Cox</surname><given-names>RD</given-names></name><name><surname>Lonie</surname><given-names>L</given-names></name><name><surname>Southam</surname><given-names>L</given-names></name><name><surname>Fraser</surname><given-names>M</given-names></name><etal/></person-group><article-title>Comparison of fluorescent single-strand conformation polymorphism analysis and denaturing high-performance liquid chromatography for detection of EXT1 and EXT2 mutations in hereditary multiple exostoses</article-title><source>Eur J Hum Genet</source><year>2000</year><volume>8</volume><fpage>24</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">10713884</pub-id></element-citation></ref><ref id="CR28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elsea</surname><given-names>SH</given-names></name><name><surname>Lucas</surname><given-names>RE</given-names></name></person-group><article-title>The mousetrap: what we can learn when the mouse model does not mimic the human disease</article-title><source>ILAR J</source><year>2002</year><volume>43</volume><fpage>66</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">11917158</pub-id></element-citation></ref><ref id="CR29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Favor</surname><given-names>J</given-names></name></person-group><article-title>A comparison of the dominant cataract and recessive specific-locus mutation rates induced by treatment of male mice with ethylnitrosourea</article-title><source>Mutat Res</source><year>1983</year><volume>110</volume><fpage>367</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">6877261</pub-id></element-citation></ref><ref id="CR30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Favor</surname><given-names>J</given-names></name></person-group><article-title>The frequency of dominant cataract and recessive specific-locus mutations in mice derived from 80 or 160 mg ethylnitrosourea per kg body weight treated spermatogonia</article-title><source>Mutat Res</source><year>1986</year><volume>162</volume><fpage>69</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">3724777</pub-id></element-citation></ref><ref id="CR31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Favor</surname><given-names>J</given-names></name><name><surname>Neuhauser-Klaus</surname><given-names>A</given-names></name></person-group><article-title>Saturation mutagenesis for dominant eye morphological defects in the mouse <italic>Mus musculus</italic></article-title><source>Mamm Genome</source><year>2000</year><volume>11</volume><fpage>520</fpage><lpage>525</lpage><pub-id pub-id-type="pmid">10886015</pub-id></element-citation></ref><ref id="CR32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Favor</surname><given-names>J</given-names></name><name><surname>Peters</surname><given-names>H</given-names></name><name><surname>Hermann</surname><given-names>T</given-names></name><name><surname>Schmahl</surname><given-names>W</given-names></name><name><surname>Chatterjee</surname><given-names>B</given-names></name><etal/></person-group><article-title>Molecular characterization of Pax6(2Neu) through Pax6(10Neu): an extension of the Pax6 allelic series and the identification of two possible hypomorph alleles in the mouse <italic>Mus musculus</italic></article-title><source>Genetics</source><year>2001</year><volume>159</volume><fpage>1689</fpage><lpage>1700</lpage><pub-id pub-id-type="pmid">11779807</pub-id></element-citation></ref><ref id="CR33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Favor</surname><given-names>J</given-names></name><name><surname>Gloeckner</surname><given-names>CJ</given-names></name><name><surname>Janik</surname><given-names>D</given-names></name><name><surname>Klempt</surname><given-names>M</given-names></name><name><surname>Neuhauser-Klaus</surname><given-names>A</given-names></name><etal/></person-group><article-title>Type IV procollagen missense mutations associated with defects of the eye, vascular stability, brain, kidney function and embryonic or postnatal viability in the mouse, <italic>Mus musculus</italic>: An extension of the Col4a1 allelic series and the identification of the first 2 Col4a2 mutant alleles</article-title><source>Genetics</source><year>2007</year><volume>175</volume><fpage>725</fpage><lpage>736</lpage><pub-id pub-id-type="pmid">17179069</pub-id></element-citation></ref><ref id="CR34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garry</surname><given-names>DJ</given-names></name><name><surname>Ordway</surname><given-names>GA</given-names></name><name><surname>Lorenz</surname><given-names>JN</given-names></name><name><surname>Radford</surname><given-names>NB</given-names></name><name><surname>Chin</surname><given-names>ER</given-names></name><etal/></person-group><article-title>Mice without myoglobin</article-title><source>Nature</source><year>1998</year><volume>395</volume><fpage>905</fpage><lpage>908</lpage><pub-id pub-id-type="pmid">9804424</pub-id></element-citation></ref><ref id="CR35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghebranious</surname><given-names>N</given-names></name><name><surname>Donehower</surname><given-names>LA</given-names></name></person-group><article-title>Mouse models in tumor suppression</article-title><source>Oncogene</source><year>1998</year><volume>17</volume><fpage>3385</fpage><lpage>3400</lpage><pub-id pub-id-type="pmid">9917000</pub-id></element-citation></ref><ref id="CR36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gidh-Jain</surname><given-names>M</given-names></name><name><surname>Takeda</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>LZ</given-names></name><name><surname>Lange</surname><given-names>AJ</given-names></name><name><surname>Vionnet</surname><given-names>N</given-names></name><etal/></person-group><article-title>Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships</article-title><source>Proc Natl Acad Sci U S A</source><year>1993</year><volume>90</volume><fpage>1932</fpage><lpage>1936</lpage><pub-id pub-id-type="pmid">8446612</pub-id></element-citation></ref><ref id="CR37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gingrich</surname><given-names>JA</given-names></name><name><surname>Hen</surname><given-names>R</given-names></name></person-group><article-title>The broken mouse: the role of development, plasticity and environment in the interpretation of phenotypic changes in knockout mice</article-title><source>Curr Opin Neurobiol</source><year>2000</year><volume>10</volume><fpage>146</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">10679442</pub-id></element-citation></ref><ref id="CR38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glenister</surname><given-names>PH</given-names></name><name><surname>Thornton</surname><given-names>CE</given-names></name></person-group><article-title>Cryoconservation&#x02014;archiving for the future</article-title><source>Mamm Genome</source><year>2000</year><volume>11</volume><fpage>565</fpage><lpage>571</lpage><pub-id pub-id-type="pmid">10886024</pub-id></element-citation></ref><ref id="CR39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gloyn</surname><given-names>AL</given-names></name></person-group><article-title>Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy</article-title><source>Hum Mutat</source><year>2003</year><volume>22</volume><fpage>353</fpage><lpage>362</lpage><pub-id pub-id-type="pmid">14517946</pub-id></element-citation></ref><ref id="CR40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graw</surname><given-names>J</given-names></name><name><surname>Klopp</surname><given-names>N</given-names></name><name><surname>Loster</surname><given-names>J</given-names></name><name><surname>Soewarto</surname><given-names>D</given-names></name><name><surname>Fuchs</surname><given-names>H</given-names></name><etal/></person-group><article-title>Ethylnitrosourea-induced mutation in mice leads to the expression of a novel protein in the eye and to dominant cataracts</article-title><source>Genetics</source><year>2001</year><volume>157</volume><fpage>1313</fpage><lpage>1320</lpage><pub-id pub-id-type="pmid">11238416</pub-id></element-citation></ref><ref id="CR41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graw</surname><given-names>J</given-names></name><name><surname>Neuhauser-Klaus</surname><given-names>A</given-names></name><name><surname>Loster</surname><given-names>J</given-names></name><name><surname>Klopp</surname><given-names>N</given-names></name><name><surname>Favor</surname><given-names>J</given-names></name></person-group><article-title>Ethylnitrosourea-induced base pair substitution affects splicing of the mouse gammaE-crystallin encoding gene leading to the expression of a hybrid protein and to a cataract</article-title><source>Genetics</source><year>2002</year><volume>161</volume><fpage>1633</fpage><lpage>1640</lpage><pub-id pub-id-type="pmid">12196406</pub-id></element-citation></ref><ref id="CR42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graw</surname><given-names>J</given-names></name><name><surname>Neuhauser-Klaus</surname><given-names>A</given-names></name><name><surname>Klopp</surname><given-names>N</given-names></name><name><surname>Selby</surname><given-names>PB</given-names></name><name><surname>Loster</surname><given-names>J</given-names></name><etal/></person-group><article-title>Genetic and allelic heterogeneity of Cryg mutations in eight distinct forms of dominant cataract in the mouse</article-title><source>Invest Ophthalmol Vis Sci</source><year>2004</year><volume>45</volume><fpage>1202</fpage><lpage>1213</lpage><pub-id pub-id-type="pmid">15037589</pub-id></element-citation></ref><ref id="CR43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graw</surname><given-names>J</given-names></name><name><surname>Loster</surname><given-names>J</given-names></name><name><surname>Puk</surname><given-names>O</given-names></name><name><surname>Munster</surname><given-names>D</given-names></name><name><surname>Haubst</surname><given-names>N</given-names></name><etal/></person-group><article-title>Three novel Pax6 alleles in the mouse leading to the same small-eye phenotype caused by different consequences at target promoters</article-title><source>Invest Ophthalmol Vis Sci</source><year>2005</year><volume>46</volume><fpage>4671</fpage><lpage>4683</lpage><pub-id pub-id-type="pmid">16303964</pub-id></element-citation></ref><ref id="CR44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greber</surname><given-names>B</given-names></name><name><surname>Lehrach</surname><given-names>H</given-names></name><name><surname>Himmelbauer</surname><given-names>H</given-names></name></person-group><article-title>Mouse splice mutant generation from ENU-treated ES cells&#x02014;a gene-driven approach</article-title><source>Genomics</source><year>2005</year><volume>85</volume><fpage>557</fpage><lpage>562</lpage><pub-id pub-id-type="pmid">15820307</pub-id></element-citation></ref><ref id="CR45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grosse</surname><given-names>J</given-names></name><name><surname>Tarnow</surname><given-names>P</given-names></name><name><surname>Rompler</surname><given-names>H</given-names></name><name><surname>Schneider</surname><given-names>B</given-names></name><name><surname>Sedlmeier</surname><given-names>R</given-names></name><etal/></person-group><article-title>N-ethyl-N-nitrosourea-based generation of mouse models for mutant G protein-coupled receptors</article-title><source>Physiol Genomics</source><year>2006</year><volume>26</volume><fpage>209</fpage><lpage>217</lpage><pub-id pub-id-type="pmid">16720677</pub-id></element-citation></ref><ref id="CR46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hafezparast</surname><given-names>M</given-names></name><name><surname>Klocke</surname><given-names>R</given-names></name><name><surname>Ruhrberg</surname><given-names>C</given-names></name><name><surname>Marquardt</surname><given-names>A</given-names></name><name><surname>Ahmad-Annuar</surname><given-names>A</given-names></name><etal/></person-group><article-title>Mutations in dynein link motor neuron degeneration to defects in retrograde transport</article-title><source>Science</source><year>2003</year><volume>300</volume><fpage>808</fpage><lpage>812</lpage><pub-id pub-id-type="pmid">12730604</pub-id></element-citation></ref><ref id="CR47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hakem</surname><given-names>R</given-names></name><name><surname>Mak</surname><given-names>TW</given-names></name></person-group><article-title>Animal models of tumor-suppressor genes</article-title><source>Annu Rev Genet</source><year>2001</year><volume>35</volume><fpage>209</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">11700283</pub-id></element-citation></ref><ref id="CR48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamosh</surname><given-names>A</given-names></name><name><surname>Scott</surname><given-names>AF</given-names></name><name><surname>Amberger</surname><given-names>JS</given-names></name><name><surname>Bocchini</surname><given-names>CA</given-names></name><name><surname>McKusick</surname><given-names>VA</given-names></name></person-group><article-title>Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders</article-title><source>Nucleic Acids Res</source><year>2005</year><volume>33</volume><fpage>D514</fpage><lpage>D517</lpage><pub-id pub-id-type="pmid">15608251</pub-id></element-citation></ref><ref id="CR49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haroutunian</surname><given-names>V</given-names></name><name><surname>Katsel</surname><given-names>P</given-names></name><name><surname>Dracheva</surname><given-names>S</given-names></name><name><surname>Davis</surname><given-names>KL</given-names></name></person-group><article-title>The human homolog of the QKI gene affected in the severe dysmyelination &#x0201c;quaking&#x0201d; mouse phenotype: downregulated in multiple brain regions in schizophrenia</article-title><source>Am J Psychiatry</source><year>2006</year><volume>163</volume><fpage>1834</fpage><lpage>1837</lpage><pub-id pub-id-type="pmid">17012699</pub-id></element-citation></ref><ref id="CR50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>AW</given-names></name><name><surname>McKie</surname><given-names>L</given-names></name><name><surname>Morgan</surname><given-names>JE</given-names></name><name><surname>Gautier</surname><given-names>P</given-names></name><name><surname>West</surname><given-names>K</given-names></name><etal/></person-group><article-title>Genotype-phenotype correlation of mouse pde6b mutations</article-title><source>Invest Ophthalmol Vis Sci</source><year>2005</year><volume>46</volume><fpage>3443</fpage><lpage>3450</lpage><pub-id pub-id-type="pmid">16123450</pub-id></element-citation></ref><ref id="CR51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermanns</surname><given-names>P</given-names></name><name><surname>Bertuch</surname><given-names>AA</given-names></name><name><surname>Bertin</surname><given-names>TK</given-names></name><name><surname>Dawson</surname><given-names>B</given-names></name><name><surname>Schmitt</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Consequences of mutations in the non-coding RMRP RNA in cartilage-hair hypoplasia</article-title><source>Hum Mol Genet</source><year>2005</year><volume>14</volume><fpage>3723</fpage><lpage>3740</lpage><pub-id pub-id-type="pmid">16254002</pub-id></element-citation></ref><ref id="CR52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hitotsumachi</surname><given-names>S</given-names></name><name><surname>Carpenter</surname><given-names>DA</given-names></name><name><surname>Russell</surname><given-names>WL</given-names></name></person-group><article-title>Dose-repetition increases the mutagenic effectiveness of N-ethyl-N-nitrosourea in mouse spermatogonia</article-title><source>Proc Natl Acad Sci U S A</source><year>1985</year><volume>82</volume><fpage>6619</fpage><lpage>6621</lpage><pub-id pub-id-type="pmid">3863118</pub-id></element-citation></ref><ref id="CR53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochgeschwender</surname><given-names>U</given-names></name><name><surname>Brennan</surname><given-names>MB</given-names></name></person-group><article-title>Mouse knockouts rule OK</article-title><source>Nature</source><year>1995</year><volume>375</volume><fpage>543</fpage><pub-id pub-id-type="pmid">7791870</pub-id></element-citation></ref><ref id="CR54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Hrabe Angelis</surname><given-names>M</given-names></name><name><surname>Balling</surname><given-names>R</given-names></name></person-group><article-title>Large scale ENU screens in the mouse: genetics meets genomics</article-title><source>Mutat Res</source><year>1998</year><volume>400</volume><fpage>25</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">9685575</pub-id></element-citation></ref><ref id="CR55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Hrabe Angelis</surname><given-names>MH</given-names></name><name><surname>Flaswinkel</surname><given-names>H</given-names></name><name><surname>Fuchs</surname><given-names>H</given-names></name><name><surname>Rathkolb</surname><given-names>B</given-names></name><name><surname>Soewarto</surname><given-names>D</given-names></name><etal/></person-group><article-title>Genome-wide, large-scale production of mutant mice by ENU mutagenesis</article-title><source>Nat Genet</source><year>2000</year><volume>25</volume><fpage>444</fpage><lpage>447</lpage><pub-id pub-id-type="pmid">10932192</pub-id></element-citation></ref><ref id="CR56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>JD</given-names></name><name><surname>Mermall</surname><given-names>V</given-names></name><name><surname>Strobel</surname><given-names>MC</given-names></name><name><surname>Russell</surname><given-names>LB</given-names></name><name><surname>Mooseker</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Molecular genetic dissection of mouse unconventional myosin-VA: tail region mutations</article-title><source>Genetics</source><year>1998</year><volume>148</volume><fpage>1963</fpage><lpage>1972</lpage><pub-id pub-id-type="pmid">9560409</pub-id></element-citation></ref><ref id="CR57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>JD</given-names></name><name><surname>Cope</surname><given-names>MJ</given-names></name><name><surname>Mermall</surname><given-names>V</given-names></name><name><surname>Strobel</surname><given-names>MC</given-names></name><name><surname>Kendrick-Jones</surname><given-names>J</given-names></name><etal/></person-group><article-title>Molecular genetic dissection of mouse unconventional myosin-VA: head region mutations</article-title><source>Genetics</source><year>1998</year><volume>148</volume><fpage>1951</fpage><lpage>1961</lpage><pub-id pub-id-type="pmid">9560408</pub-id></element-citation></ref><ref id="CR58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Im</surname><given-names>WB</given-names></name><name><surname>Phelps</surname><given-names>SF</given-names></name><name><surname>Copen</surname><given-names>EH</given-names></name><name><surname>Adams</surname><given-names>EG</given-names></name><name><surname>Slightom</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Differential expression of dystrophin isoforms in strains of mdx mice with different mutations</article-title><source>Hum Mol Genet</source><year>1996</year><volume>5</volume><fpage>1149</fpage><lpage>1153</lpage><pub-id pub-id-type="pmid">8842734</pub-id></element-citation></ref><ref id="CR59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>M</given-names></name><name><surname>Sakuraba</surname><given-names>Y</given-names></name><name><surname>Motegi</surname><given-names>H</given-names></name><name><surname>Kubota</surname><given-names>N</given-names></name><name><surname>Toki</surname><given-names>H</given-names></name><etal/></person-group><article-title>A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program</article-title><source>Hum Mol Genet</source><year>2004</year><volume>13</volume><fpage>1147</fpage><lpage>1157</lpage><pub-id pub-id-type="pmid">15102714</pub-id></element-citation></ref><ref id="CR60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ionasescu</surname><given-names>VV</given-names></name><name><surname>Searby</surname><given-names>CC</given-names></name><name><surname>Ionasescu</surname><given-names>R</given-names></name><name><surname>Chatkupt</surname><given-names>S</given-names></name><name><surname>Patel</surname><given-names>N</given-names></name><etal/></person-group><article-title>Dejerine-Sottas neuropathy in mother and son with same point mutation of PMP22 gene</article-title><source>Muscle Nerve</source><year>1997</year><volume>20</volume><fpage>97</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">8995589</pub-id></element-citation></ref><ref id="CR61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isaacs</surname><given-names>AM</given-names></name><name><surname>Davies</surname><given-names>KE</given-names></name><name><surname>Hunter</surname><given-names>AJ</given-names></name><name><surname>Nolan</surname><given-names>PM</given-names></name><name><surname>Vizor</surname><given-names>L</given-names></name><etal/></person-group><article-title>Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy</article-title><source>Hum Mol Genet</source><year>2000</year><volume>9</volume><fpage>1865</fpage><lpage>1871</lpage><pub-id pub-id-type="pmid">10915775</pub-id></element-citation></ref><ref id="CR62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isaacs</surname><given-names>AM</given-names></name><name><surname>Jeans</surname><given-names>A</given-names></name><name><surname>Oliver</surname><given-names>PL</given-names></name><name><surname>Vizor</surname><given-names>L</given-names></name><name><surname>Brown</surname><given-names>SD</given-names></name><etal/></person-group><article-title>Identification of a new Pmp22 mouse mutant and trafficking analysis of a Pmp22 allelic series suggesting that protein aggregates may be protective in Pmp22-associated peripheral neuropathy</article-title><source>Mol Cell Neurosci</source><year>2002</year><volume>21</volume><fpage>114</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">12359155</pub-id></element-citation></ref><ref id="CR63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isaacs</surname><given-names>AM</given-names></name><name><surname>Oliver</surname><given-names>PL</given-names></name><name><surname>Jones</surname><given-names>EL</given-names></name><name><surname>Jeans</surname><given-names>A</given-names></name><name><surname>Potter</surname><given-names>A</given-names></name><etal/></person-group><article-title>A mutation in Af4 is predicted to cause cerebellar ataxia and cataracts in the robotic mouse</article-title><source>J Neurosci</source><year>2003</year><volume>23</volume><fpage>1631</fpage><lpage>1637</lpage><pub-id pub-id-type="pmid">12629167</pub-id></element-citation></ref><ref id="CR64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isnard</surname><given-names>P</given-names></name><name><surname>Core</surname><given-names>N</given-names></name><name><surname>Naquet</surname><given-names>P</given-names></name><name><surname>Djabali</surname><given-names>M</given-names></name></person-group><article-title>Altered lymphoid development in mice deficient for the mAF4 proto-oncogene</article-title><source>Blood</source><year>2000</year><volume>96</volume><fpage>705</fpage><lpage>710</lpage><pub-id pub-id-type="pmid">10887138</pub-id></element-citation></ref><ref id="CR65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Justice</surname><given-names>MJ</given-names></name></person-group><article-title>Capitalizing on large-scale mouse mutagenesis screens</article-title><source>Nat Rev Genet</source><year>2000</year><volume>1</volume><fpage>109</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">11253650</pub-id></element-citation></ref><ref id="CR66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Justice</surname><given-names>MJ</given-names></name><name><surname>Bode</surname><given-names>VC</given-names></name></person-group><article-title>Three ENU-induced alleles of the murine quaking locus are recessive embryonic lethal mutations</article-title><source>Genet Res</source><year>1988</year><volume>51</volume><fpage>95</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">3410318</pub-id></element-citation></ref><ref id="CR67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaku</surname><given-names>K</given-names></name><name><surname>Fiedorek</surname><given-names>FT</given-names><suffix>Jr</suffix></name><name><surname>Province</surname><given-names>M</given-names></name><name><surname>Permutt</surname><given-names>MA</given-names></name></person-group><article-title>Genetic analysis of glucose tolerance in inbred mouse strains. Evidence for polygenic control</article-title><source>Diabetes</source><year>1988</year><volume>37</volume><fpage>707</fpage><lpage>713</lpage><pub-id pub-id-type="pmid">3289991</pub-id></element-citation></ref><ref id="CR68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keays</surname><given-names>DA</given-names></name><name><surname>Nolan</surname><given-names>PM</given-names></name></person-group><article-title>N-ethyl-N-nitrosourea mouse mutants in the dissection of behavioural and psychiatric disorders</article-title><source>Eur J Pharmacol</source><year>2003</year><volume>480</volume><fpage>205</fpage><lpage>217</lpage><pub-id pub-id-type="pmid">14623363</pub-id></element-citation></ref><ref id="CR69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keays</surname><given-names>DA</given-names></name><name><surname>Clark</surname><given-names>TG</given-names></name><name><surname>Flint</surname><given-names>J</given-names></name></person-group><article-title>Estimating the number of coding mutations in genotypic- and phenotypic-driven N-ethyl-N-nitrosourea (ENU) screens</article-title><source>Mamm Genome</source><year>2006</year><volume>17</volume><fpage>230</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">16518690</pub-id></element-citation></ref><ref id="CR70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keays</surname><given-names>DA</given-names></name><name><surname>Tian</surname><given-names>G</given-names></name><name><surname>Poirier</surname><given-names>K</given-names></name><name><surname>Huang</surname><given-names>GJ</given-names></name><name><surname>Siebold</surname><given-names>C</given-names></name><etal/></person-group><article-title>Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans</article-title><source>Cell</source><year>2007</year><volume>128</volume><fpage>45</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">17218254</pub-id></element-citation></ref><ref id="CR71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiernan</surname><given-names>AE</given-names></name><name><surname>Erven</surname><given-names>A</given-names></name><name><surname>Voegeling</surname><given-names>S</given-names></name><name><surname>Peters</surname><given-names>J</given-names></name><name><surname>Nolan</surname><given-names>P</given-names></name><etal/></person-group><article-title>ENU mutagenesis reveals a highly mutable locus on mouse Chromosome 4 that affects ear morphogenesis</article-title><source>Mamm Genome</source><year>2002</year><volume>13</volume><fpage>142</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">11919684</pub-id></element-citation></ref><ref id="CR72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kono</surname><given-names>M</given-names></name><name><surname>Mi</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Allende</surname><given-names>ML</given-names></name><etal/></person-group><article-title>The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>29367</fpage><lpage>29373</lpage><pub-id pub-id-type="pmid">15138255</pub-id></element-citation></ref><ref id="CR73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuznetsov</surname><given-names>VV</given-names></name></person-group><article-title>RNA interference. An approach to produce knockout organisms and cell lines</article-title><source>Biochemistry (Mosc)</source><year>2003</year><volume>68</volume><fpage>1063</fpage><lpage>1076</lpage><pub-id pub-id-type="pmid">14616076</pub-id></element-citation></ref><ref id="CR74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalouette</surname><given-names>A</given-names></name><name><surname>Guenet</surname><given-names>JL</given-names></name><name><surname>Vriz</surname><given-names>S</given-names></name></person-group><article-title>Hotfoot mouse mutations affect the delta 2 glutamate receptor gene and are allelic to lurcher</article-title><source>Genomics</source><year>1998</year><volume>50</volume><fpage>9</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">9628817</pub-id></element-citation></ref><ref id="CR75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeRoith</surname><given-names>D</given-names></name><name><surname>Gavrilova</surname><given-names>O</given-names></name></person-group><article-title>Mouse models created to study the pathophysiology of Type 2 diabetes</article-title><source>Int J Biochem Cell Biol</source><year>2006</year><volume>38</volume><fpage>904</fpage><lpage>912</lpage><pub-id pub-id-type="pmid">16103004</pub-id></element-citation></ref><ref id="CR76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lettice</surname><given-names>LA</given-names></name><name><surname>Horikoshi</surname><given-names>T</given-names></name><name><surname>Heaney</surname><given-names>SJ</given-names></name><name><surname>van Baren</surname><given-names>MJ</given-names></name><name><surname>van der Linde</surname><given-names>HC</given-names></name><etal/></person-group><article-title>Disruption of a long-range cis-acting regulator for Shh causes preaxial polydactyly</article-title><source>Proc Natl Acad Sci U S A</source><year>2002</year><volume>99</volume><fpage>7548</fpage><lpage>7553</lpage><pub-id pub-id-type="pmid">12032320</pub-id></element-citation></ref><ref id="CR77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lettice</surname><given-names>LA</given-names></name><name><surname>Heaney</surname><given-names>SJ</given-names></name><name><surname>Purdie</surname><given-names>LA</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>de Beer</surname><given-names>P</given-names></name><etal/></person-group><article-title>A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly</article-title><source>Hum Mol Genet</source><year>2003</year><volume>12</volume><fpage>1725</fpage><lpage>1735</lpage><pub-id pub-id-type="pmid">12837695</pub-id></element-citation></ref><ref id="CR78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letts</surname><given-names>VA</given-names></name><name><surname>Kang</surname><given-names>MG</given-names></name><name><surname>Mahaffey</surname><given-names>CL</given-names></name><name><surname>Beyer</surname><given-names>B</given-names></name><name><surname>Tenbrink</surname><given-names>H</given-names></name><etal/></person-group><article-title>Phenotypic heterogeneity in the stargazin allelic series</article-title><source>Mamm Genome</source><year>2003</year><volume>14</volume><fpage>506</fpage><lpage>513</lpage><pub-id pub-id-type="pmid">12925883</pub-id></element-citation></ref><ref id="CR79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenzetti</surname><given-names>D</given-names></name><name><surname>Bishop</surname><given-names>CE</given-names></name><name><surname>Justice</surname><given-names>MJ</given-names></name></person-group><article-title>Deletion of the Parkin coregulated gene causes male sterility in the quaking(viable) mouse mutant</article-title><source>Proc Natl Acad Sci U S A</source><year>2004</year><volume>101</volume><fpage>8402</fpage><lpage>8407</lpage><pub-id pub-id-type="pmid">15148410</pub-id></element-citation></ref><ref id="CR80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maas</surname><given-names>SA</given-names></name><name><surname>Fallon</surname><given-names>JF</given-names></name></person-group><article-title>Single base pair change in the long-range Sonic hedgehog limb-specific enhancer is a genetic basis for preaxial polydactyly</article-title><source>Dev Dyn</source><year>2005</year><volume>232</volume><fpage>345</fpage><lpage>348</lpage><pub-id pub-id-type="pmid">15637698</pub-id></element-citation></ref><ref id="CR81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marker</surname><given-names>PC</given-names></name><name><surname>Seung</surname><given-names>K</given-names></name><name><surname>Bland</surname><given-names>AE</given-names></name><name><surname>Russell</surname><given-names>LB</given-names></name><name><surname>Kingsley</surname><given-names>DM</given-names></name></person-group><article-title>Spectrum of Bmp5 mutations from germline mutagenesis experiments in mice</article-title><source>Genetics</source><year>1997</year><volume>145</volume><fpage>435</fpage><lpage>443</lpage><pub-id pub-id-type="pmid">9071596</pub-id></element-citation></ref><ref id="CR82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marques</surname><given-names>W</given-names><suffix>Jr</suffix></name><name><surname>Thomas</surname><given-names>PK</given-names></name><name><surname>Sweeney</surname><given-names>MG</given-names></name><name><surname>Carr</surname><given-names>L</given-names></name><name><surname>Wood</surname><given-names>NW</given-names></name></person-group><article-title>Dejerine-Sottas neuropathy and PMP22 point mutations: a new base pair substitution and a possible &#x0201c;hot spot&#x0201d; on Ser72</article-title><source>Ann Neurol</source><year>1998</year><volume>43</volume><fpage>680</fpage><lpage>683</lpage><pub-id pub-id-type="pmid">9585367</pub-id></element-citation></ref><ref id="CR83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marques</surname><given-names>W</given-names><suffix>Jr</suffix></name><name><surname>Neto</surname><given-names>JM</given-names></name><name><surname>Barreira</surname><given-names>AA</given-names></name></person-group><article-title>Dejerine-Sottas neuropathy caused by the missense mutation PMP22 Ser72Leu</article-title><source>Acta Neurol Scand</source><year>2004</year><volume>110</volume><fpage>196</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">15285778</pub-id></element-citation></ref><ref id="CR84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masuya</surname><given-names>H</given-names></name><name><surname>Sezutsu</surname><given-names>H</given-names></name><name><surname>Sakuraba</surname><given-names>Y</given-names></name><name><surname>Sagai</surname><given-names>T</given-names></name><name><surname>Hosoya</surname><given-names>M</given-names></name><etal/></person-group><article-title>A series of ENU-induced single-base substitutions in a long-range cis-element altering Sonic hedgehog expression in the developing mouse limb bud</article-title><source>Genomics</source><year>2007</year><volume>89</volume><fpage>207</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">17049204</pub-id></element-citation></ref><ref id="CR85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mburu</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>XZ</given-names></name><name><surname>Walsh</surname><given-names>J</given-names></name><name><surname>Saw</surname><given-names>D</given-names><suffix>Jr</suffix></name><name><surname>Cope</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Mutation analysis of the mouse myosin VIIA deafness gene</article-title><source>Genes Funct</source><year>1997</year><volume>1</volume><fpage>191</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">9680294</pub-id></element-citation></ref><ref id="CR86"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>McKusick</surname><given-names>VA</given-names></name></person-group><source>Mendelian Inheritance in Man</source><year>1998</year><edition>12</edition><publisher-loc>Baltimore, MD</publisher-loc><publisher-name>Johns Hopkins University Press</publisher-name></element-citation></ref><ref id="CR87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLaughlin</surname><given-names>ME</given-names></name><name><surname>Ehrhart</surname><given-names>TL</given-names></name><name><surname>Berson</surname><given-names>EL</given-names></name><name><surname>Dryja</surname><given-names>TP</given-names></name></person-group><article-title>Mutation spectrum of the gene encoding the beta subunit of rod phosphodiesterase among patients with autosomal recessive retinitis pigmentosa</article-title><source>Proc Natl Acad Sci U S A</source><year>1995</year><volume>92</volume><fpage>3249</fpage><lpage>3253</lpage><pub-id pub-id-type="pmid">7724547</pub-id></element-citation></ref><ref id="CR88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meehan</surname><given-names>TP</given-names></name><name><surname>Tabeta</surname><given-names>K</given-names></name><name><surname>Du</surname><given-names>X</given-names></name><name><surname>Woodward</surname><given-names>LS</given-names></name><name><surname>Firozi</surname><given-names>K</given-names></name><etal/></person-group><article-title>Point mutations in the melanocortin-4 receptor cause variable obesity in mice</article-title><source>Mamm Genome</source><year>2006</year><volume>17</volume><fpage>1162</fpage><lpage>1171</lpage><pub-id pub-id-type="pmid">17143585</pub-id></element-citation></ref><ref id="CR89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meeson</surname><given-names>AP</given-names></name><name><surname>Radford</surname><given-names>N</given-names></name><name><surname>Shelton</surname><given-names>JM</given-names></name><name><surname>Mammen</surname><given-names>PP</given-names></name><name><surname>DiMaio</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Adaptive mechanisms that preserve cardiac function in mice without myoglobin</article-title><source>Circ Res</source><year>2001</year><volume>88</volume><fpage>713</fpage><lpage>720</lpage><pub-id pub-id-type="pmid">11304494</pub-id></element-citation></ref><ref id="CR90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michaud</surname><given-names>EJ</given-names></name><name><surname>Culiat</surname><given-names>CT</given-names></name><name><surname>Klebig</surname><given-names>ML</given-names></name><name><surname>Barker</surname><given-names>PE</given-names></name><name><surname>Cain</surname><given-names>KT</given-names></name><etal/></person-group><article-title>Efficient gene-driven germ-line point mutagenesis of C57BL/6J mice</article-title><source>BMC Genomics</source><year>2005</year><volume>6</volume><fpage>164</fpage><pub-id pub-id-type="pmid">16300676</pub-id></element-citation></ref><ref id="CR91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyaki</surname><given-names>M</given-names></name><name><surname>Kuroki</surname><given-names>T</given-names></name></person-group><article-title>Role of Smad4 (DPC4) inactivation in human cancer</article-title><source>Biochem Biophys Res Commun</source><year>2003</year><volume>306</volume><fpage>799</fpage><lpage>804</lpage><pub-id pub-id-type="pmid">12821112</pub-id></element-citation></ref><ref id="CR92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munroe</surname><given-names>RJ</given-names></name><name><surname>Ackerman</surname><given-names>SL</given-names></name><name><surname>Schimenti</surname><given-names>JC</given-names></name></person-group><article-title>Genomewide two-generation screens for recessive mutations by ES cell mutagenesis</article-title><source>Mamm Genome</source><year>2004</year><volume>15</volume><fpage>960</fpage><lpage>965</lpage><pub-id pub-id-type="pmid">15599554</pub-id></element-citation></ref><ref id="CR93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ning</surname><given-names>Y</given-names></name><name><surname>Schuller</surname><given-names>AG</given-names></name><name><surname>Bradshaw</surname><given-names>S</given-names></name><name><surname>Rotwein</surname><given-names>P</given-names></name><name><surname>Ludwig</surname><given-names>T</given-names></name><etal/></person-group><article-title>Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein-3, -4, and -5</article-title><source>Mol Endocrinol</source><year>2006</year><volume>20</volume><fpage>2173</fpage><lpage>2186</lpage><pub-id pub-id-type="pmid">16675541</pub-id></element-citation></ref><ref id="CR94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Njolstad</surname><given-names>PR</given-names></name><name><surname>Sovik</surname><given-names>O</given-names></name><name><surname>Cuesta-Munoz</surname><given-names>A</given-names></name><name><surname>Bjorkhaug</surname><given-names>L</given-names></name><name><surname>Massa</surname><given-names>O</given-names></name><etal/></person-group><article-title>Neonatal diabetes mellitus due to complete glucokinase deficiency</article-title><source>N Engl J Med</source><year>2001</year><volume>344</volume><fpage>1588</fpage><lpage>1592</lpage><pub-id pub-id-type="pmid">11372010</pub-id></element-citation></ref><ref id="CR95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nolan</surname><given-names>PM</given-names></name><name><surname>Peters</surname><given-names>J</given-names></name><name><surname>Strivens</surname><given-names>M</given-names></name><name><surname>Rogers</surname><given-names>D</given-names></name><name><surname>Hagan</surname><given-names>J</given-names></name><etal/></person-group><article-title>A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse</article-title><source>Nat Genet</source><year>2000</year><volume>25</volume><fpage>440</fpage><lpage>443</lpage><pub-id pub-id-type="pmid">10932191</pub-id></element-citation></ref><ref id="CR96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noveroske</surname><given-names>JK</given-names></name><name><surname>Hardy</surname><given-names>R</given-names></name><name><surname>Dapper</surname><given-names>JD</given-names></name><name><surname>Vogel</surname><given-names>H</given-names></name><name><surname>Justice</surname><given-names>MJ</given-names></name></person-group><article-title>A new ENU-induced allele of mouse quaking causes severe CNS dysmyelination</article-title><source>Mamm Genome</source><year>2005</year><volume>16</volume><fpage>672</fpage><lpage>682</lpage><pub-id pub-id-type="pmid">16245024</pub-id></element-citation></ref><ref id="CR97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliver</surname><given-names>PL</given-names></name><name><surname>Bitoun</surname><given-names>E</given-names></name><name><surname>Clark</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>EL</given-names></name><name><surname>Davies</surname><given-names>KE</given-names></name></person-group><article-title>Mediation of Af4 protein function in the cerebellum by Siah proteins</article-title><source>Proc Natl Acad Sci U S A</source><year>2004</year><volume>101</volume><fpage>14901</fpage><lpage>14906</lpage><pub-id pub-id-type="pmid">15459319</pub-id></element-citation></ref><ref id="CR98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olson</surname><given-names>EN</given-names></name><name><surname>Arnold</surname><given-names>HH</given-names></name><name><surname>Rigby</surname><given-names>PW</given-names></name><name><surname>Wold</surname><given-names>BJ</given-names></name></person-group><article-title>Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4</article-title><source>Cell</source><year>1996</year><volume>85</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">8620528</pub-id></element-citation></ref><ref id="CR99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patrucco</surname><given-names>E</given-names></name><name><surname>Notte</surname><given-names>A</given-names></name><name><surname>Barberis</surname><given-names>L</given-names></name><name><surname>Selvetella</surname><given-names>G</given-names></name><name><surname>Maffei</surname><given-names>A</given-names></name><etal/></person-group><article-title>PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects</article-title><source>Cell</source><year>2004</year><volume>118</volume><fpage>375</fpage><lpage>387</lpage><pub-id pub-id-type="pmid">15294162</pub-id></element-citation></ref><ref id="CR100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pazzaglia</surname><given-names>S</given-names></name></person-group><article-title>Ptc1 heterozygous knockout mice as a model of multi-organ tumorigenesis</article-title><source>Cancer Lett</source><year>2006</year><volume>234</volume><fpage>124</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">15925443</pub-id></element-citation></ref><ref id="CR101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearce</surname><given-names>SR</given-names></name><name><surname>Peters</surname><given-names>J</given-names></name><name><surname>Ball</surname><given-names>S</given-names></name><name><surname>Morgan</surname><given-names>MJ</given-names></name><name><surname>Walker</surname><given-names>JI</given-names></name><etal/></person-group><article-title>Sequence characterization of ENU-induced mutants of glucose phosphate isomerase in mouse</article-title><source>Mamm Genome</source><year>1995</year><volume>6</volume><fpage>858</fpage><lpage>861</lpage><pub-id pub-id-type="pmid">8747924</pub-id></element-citation></ref><ref id="CR102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porret</surname><given-names>A</given-names></name><name><surname>Merillat</surname><given-names>AM</given-names></name><name><surname>Guichard</surname><given-names>S</given-names></name><name><surname>Beermann</surname><given-names>F</given-names></name><name><surname>Hummler</surname><given-names>E</given-names></name></person-group><article-title>Tissue-specific transgenic and knockout mice</article-title><source>Methods Mol Biol</source><year>2006</year><volume>337</volume><fpage>185</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">16929948</pub-id></element-citation></ref><ref id="CR103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Postic</surname><given-names>C</given-names></name><name><surname>Shiota</surname><given-names>M</given-names></name><name><surname>Niswender</surname><given-names>KD</given-names></name><name><surname>Jetton</surname><given-names>TL</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>305</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">9867845</pub-id></element-citation></ref><ref id="CR104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poueymirou</surname><given-names>WT</given-names></name><name><surname>Auerbach</surname><given-names>W</given-names></name><name><surname>Frendewey</surname><given-names>D</given-names></name><name><surname>Hickey</surname><given-names>JF</given-names></name><name><surname>Escaravage</surname><given-names>JM</given-names></name><etal/></person-group><article-title>F0 generation mice fully derived from gene-targeted embryonic stem cells allowing immediate phenotypic analyses</article-title><source>Nat Biotechnol</source><year>2007</year><volume>25</volume><fpage>91</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">17187059</pub-id></element-citation></ref><ref id="CR105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pretsch</surname><given-names>W</given-names></name><name><surname>Chatterjee</surname><given-names>B</given-names></name><name><surname>Favor</surname><given-names>J</given-names></name><name><surname>Merkle</surname><given-names>S</given-names></name><name><surname>Sandulache</surname><given-names>R</given-names></name></person-group><article-title>Molecular, genetic and biochemical characterization of lactate dehydrogenase-A enzyme activity mutations in <italic>Mus musculus</italic></article-title><source>Mamm Genome</source><year>1998</year><volume>9</volume><fpage>144</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">9457676</pub-id></element-citation></ref><ref id="CR106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quwailid</surname><given-names>MM</given-names></name><name><surname>Hugill</surname><given-names>A</given-names></name><name><surname>Dear</surname><given-names>N</given-names></name><name><surname>Vizor</surname><given-names>L</given-names></name><name><surname>Wells</surname><given-names>S</given-names></name><etal/></person-group><article-title>A gene-driven ENU-based approach to generating an allelic series in any gene</article-title><source>Mamm Genome</source><year>2004</year><volume>15</volume><fpage>585</fpage><lpage>591</lpage><pub-id pub-id-type="pmid">15457338</pub-id></element-citation></ref><ref id="CR107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>DC</given-names></name><name><surname>Fisher</surname><given-names>EM</given-names></name><name><surname>Brown</surname><given-names>SD</given-names></name><name><surname>Peters</surname><given-names>J</given-names></name><name><surname>Hunter</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment</article-title><source>Mamm Genome</source><year>1997</year><volume>8</volume><fpage>711</fpage><lpage>713</lpage><pub-id pub-id-type="pmid">9321461</pub-id></element-citation></ref><ref id="CR108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenecker</surname><given-names>J</given-names></name><name><surname>Huth</surname><given-names>S</given-names></name><name><surname>Rudolph</surname><given-names>C</given-names></name></person-group><article-title>Gene therapy for cystic fibrosis lung disease: current status and future perspectives</article-title><source>Curr Opin Mol Ther</source><year>2006</year><volume>8</volume><fpage>439</fpage><lpage>445</lpage><pub-id pub-id-type="pmid">17078386</pub-id></element-citation></ref><ref id="CR109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Routtenberg</surname><given-names>A</given-names></name></person-group><article-title>Knockout mouse fault lines</article-title><source>Nature</source><year>1995</year><volume>374</volume><fpage>314</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">7885468</pub-id></element-citation></ref><ref id="CR110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Runkel</surname><given-names>F</given-names></name><name><surname>Marquardt</surname><given-names>A</given-names></name><name><surname>Stoeger</surname><given-names>C</given-names></name><name><surname>Kochmann</surname><given-names>E</given-names></name><name><surname>Simon</surname><given-names>D</given-names></name><etal/></person-group><article-title>The dominant alopecia phenotypes Bareskin, Rex-denuded, and Reduced Coat 2 are caused by mutations in gasdermin 3</article-title><source>Genomics</source><year>2004</year><volume>84</volume><fpage>824</fpage><lpage>835</lpage><pub-id pub-id-type="pmid">15475261</pub-id></element-citation></ref><ref id="CR111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russ</surname><given-names>A</given-names></name><name><surname>Stumm</surname><given-names>G</given-names></name><name><surname>Augustin</surname><given-names>M</given-names></name><name><surname>Sedlmeier</surname><given-names>R</given-names></name><name><surname>Wattler</surname><given-names>S</given-names></name><etal/></person-group><article-title>Random mutagenesis in the mouse as a tool in drug discovery</article-title><source>Drug Discov Today</source><year>2002</year><volume>7</volume><fpage>1175</fpage><lpage>1183</lpage><pub-id pub-id-type="pmid">12547018</pub-id></element-citation></ref><ref id="CR112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagai</surname><given-names>T</given-names></name><name><surname>Masuya</surname><given-names>H</given-names></name><name><surname>Tamura</surname><given-names>M</given-names></name><name><surname>Shimizu</surname><given-names>K</given-names></name><name><surname>Yada</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Phylogenetic conservation of a limb-specific, cis-acting regulator of Sonic hedgehog (Shh)</article-title><source>Mamm Genome</source><year>2004</year><volume>15</volume><fpage>23</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">14727139</pub-id></element-citation></ref><ref id="CR113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakuraba</surname><given-names>Y</given-names></name><name><surname>Sezutsu</surname><given-names>H</given-names></name><name><surname>Takahasi</surname><given-names>KR</given-names></name><name><surname>Tsuchihashi</surname><given-names>K</given-names></name><name><surname>Ichikawa</surname><given-names>R</given-names></name><etal/></person-group><article-title>Molecular characterization of ENU mouse mutagenesis and archives</article-title><source>Biochem Biophys Res Commun</source><year>2005</year><volume>336</volume><fpage>609</fpage><lpage>616</lpage><pub-id pub-id-type="pmid">16139793</pub-id></element-citation></ref><ref id="CR114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandulache</surname><given-names>R</given-names></name><name><surname>Pretsch</surname><given-names>W</given-names></name><name><surname>Chatterjee</surname><given-names>B</given-names></name><name><surname>Gimbel</surname><given-names>W</given-names></name><name><surname>Graw</surname><given-names>J</given-names></name><etal/></person-group><article-title>Molecular analysis of four lactate dehydrogenase-A mutants in the mouse</article-title><source>Mamm Genome</source><year>1994</year><volume>5</volume><fpage>777</fpage><lpage>780</lpage><pub-id pub-id-type="pmid">7534515</pub-id></element-citation></ref><ref id="CR115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sangiuolo</surname><given-names>F</given-names></name><name><surname>Novelli</surname><given-names>G</given-names></name></person-group><article-title>Sequence-specific modification of mouse genomic DNA mediated by gene targeting techniques</article-title><source>Cytogenet Genome Res</source><year>2004</year><volume>105</volume><fpage>435</fpage><lpage>441</lpage><pub-id pub-id-type="pmid">15237231</pub-id></element-citation></ref><ref id="CR116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shastry</surname><given-names>BS</given-names></name></person-group><article-title>Gene disruption in mice: models of development and disease</article-title><source>Mol Cell Biochem</source><year>1998</year><volume>181</volume><fpage>163</fpage><lpage>179</lpage><pub-id pub-id-type="pmid">9562253</pub-id></element-citation></ref><ref id="CR117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheahan</surname><given-names>S</given-names></name><name><surname>Bellamy</surname><given-names>CO</given-names></name><name><surname>Treanor</surname><given-names>L</given-names></name><name><surname>Harrison</surname><given-names>DJ</given-names></name><name><surname>Prost</surname><given-names>S</given-names></name></person-group><article-title>Additive effect of p53, p21 and Rb deletion in triple knockout primary hepatocytes</article-title><source>Oncogene</source><year>2004</year><volume>23</volume><fpage>1489</fpage><lpage>1497</lpage><pub-id pub-id-type="pmid">14647424</pub-id></element-citation></ref><ref id="CR118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snouwaert</surname><given-names>JN</given-names></name><name><surname>Brigman</surname><given-names>KK</given-names></name><name><surname>Latour</surname><given-names>AM</given-names></name><name><surname>Malouf</surname><given-names>NN</given-names></name><name><surname>Boucher</surname><given-names>RC</given-names></name><etal/></person-group><article-title>An animal model for cystic fibrosis made by gene targeting</article-title><source>Science</source><year>1992</year><volume>257</volume><fpage>1083</fpage><lpage>1088</lpage><pub-id pub-id-type="pmid">1380723</pub-id></element-citation></ref><ref id="CR119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solberg</surname><given-names>LC</given-names></name><name><surname>Valdar</surname><given-names>W</given-names></name><name><surname>Gauguier</surname><given-names>D</given-names></name><name><surname>Nunez</surname><given-names>G</given-names></name><name><surname>Taylor</surname><given-names>A</given-names></name><etal/></person-group><article-title>A protocol for high-throughput phenotyping, suitable for quantitative trait analysis in mice</article-title><source>Mamm Genome</source><year>2006</year><volume>17</volume><fpage>129</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">16465593</pub-id></element-citation></ref><ref id="CR120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stenson</surname><given-names>PD</given-names></name><name><surname>Ball</surname><given-names>EV</given-names></name><name><surname>Mort</surname><given-names>M</given-names></name><name><surname>Phillips</surname><given-names>AD</given-names></name><name><surname>Shiel</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Human Gene Mutation Database (HGMD): 2003 update</article-title><source>Hum Mutat</source><year>2003</year><volume>21</volume><fpage>577</fpage><lpage>581</lpage><pub-id pub-id-type="pmid">12754702</pub-id></element-citation></ref><ref id="CR121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suter</surname><given-names>U</given-names></name><name><surname>Moskow</surname><given-names>JJ</given-names></name><name><surname>Welcher</surname><given-names>AA</given-names></name><name><surname>Snipes</surname><given-names>GJ</given-names></name><name><surname>Kosaras</surname><given-names>B</given-names></name><etal/></person-group><article-title>A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse</article-title><source>Proc Natl Acad Sci U S A</source><year>1992</year><volume>89</volume><fpage>4382</fpage><lpage>4386</lpage><pub-id pub-id-type="pmid">1374899</pub-id></element-citation></ref><ref id="CR122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thaung</surname><given-names>C</given-names></name><name><surname>West</surname><given-names>K</given-names></name><name><surname>Clark</surname><given-names>BJ</given-names></name><name><surname>McKie</surname><given-names>L</given-names></name><name><surname>Morgan</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Novel ENU-induced eye mutations in the mouse: models for human eye disease</article-title><source>Hum Mol Genet</source><year>2002</year><volume>11</volume><fpage>755</fpage><lpage>767</lpage><pub-id pub-id-type="pmid">11929848</pub-id></element-citation></ref><ref id="CR123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toye</surname><given-names>AA</given-names></name><name><surname>Moir</surname><given-names>L</given-names></name><name><surname>Hugill</surname><given-names>A</given-names></name><name><surname>Bentley</surname><given-names>L</given-names></name><name><surname>Quarterman</surname><given-names>J</given-names></name><etal/></person-group><article-title>A new mouse model of type 2 diabetes, produced by N-ethyl-nitrosourea mutagenesis, is the result of a missense mutation in the glucokinase gene</article-title><source>Diabetes</source><year>2004</year><volume>53</volume><fpage>1577</fpage><lpage>1583</lpage><pub-id pub-id-type="pmid">15161764</pub-id></element-citation></ref><ref id="CR124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valentijn</surname><given-names>LJ</given-names></name><name><surname>Baas</surname><given-names>F</given-names></name><name><surname>Wolterman</surname><given-names>RA</given-names></name><name><surname>Hoogendijk</surname><given-names>JE</given-names></name><name><surname>van den Bosch</surname><given-names>NH</given-names></name><etal/></person-group><article-title>Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A</article-title><source>Nat Genet</source><year>1992</year><volume>2</volume><fpage>288</fpage><lpage>291</lpage><pub-id pub-id-type="pmid">1303281</pub-id></element-citation></ref><ref id="CR125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valentijn</surname><given-names>LJ</given-names></name><name><surname>Ouvrier</surname><given-names>RA</given-names></name><name><surname>van den Bosch</surname><given-names>NH</given-names></name><name><surname>Bolhuis</surname><given-names>PA</given-names></name><name><surname>Baas</surname><given-names>F</given-names></name><etal/></person-group><article-title>Dejerine-Sottas neuropathy is associated with a de novo PMP22 mutation</article-title><source>Hum Mutat</source><year>1995</year><volume>5</volume><fpage>76</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">7728152</pub-id></element-citation></ref><ref id="CR126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vionnet</surname><given-names>N</given-names></name><name><surname>Stoffel</surname><given-names>M</given-names></name><name><surname>Takeda</surname><given-names>J</given-names></name><name><surname>Yasuda</surname><given-names>K</given-names></name><name><surname>Bell</surname><given-names>GI</given-names></name><etal/></person-group><article-title>Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus</article-title><source>Nature</source><year>1992</year><volume>356</volume><fpage>721</fpage><lpage>722</lpage><pub-id pub-id-type="pmid">1570017</pub-id></element-citation></ref><ref id="CR127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visscher</surname><given-names>PM</given-names></name><name><surname>Haley</surname><given-names>CS</given-names></name><name><surname>Thompson</surname><given-names>R</given-names></name></person-group><article-title>Marker-assisted introgression in backcross breeding programs</article-title><source>Genetics</source><year>1996</year><volume>144</volume><fpage>1923</fpage><lpage>1932</lpage><pub-id pub-id-type="pmid">8978075</pub-id></element-citation></ref><ref id="CR128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vivian</surname><given-names>JL</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yee</surname><given-names>D</given-names></name><name><surname>Schneider</surname><given-names>E</given-names></name><name><surname>Magnuson</surname><given-names>T</given-names></name></person-group><article-title>An allelic series of mutations in Smad2 and Smad4 identified in a genotype-based screen of N-ethyl-N- nitrosourea-mutagenized mouse embryonic stem cells</article-title><source>Proc Natl Acad Sci U S A</source><year>2002</year><volume>99</volume><fpage>15542</fpage><lpage>15547</lpage><pub-id pub-id-type="pmid">12432092</pub-id></element-citation></ref><ref id="CR129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walke</surname><given-names>DW</given-names></name><name><surname>Han</surname><given-names>C</given-names></name><name><surname>Shaw</surname><given-names>J</given-names></name><name><surname>Wann</surname><given-names>E</given-names></name><name><surname>Zambrowicz</surname><given-names>B</given-names></name><etal/></person-group><article-title>In vivo drug target discovery: identifying the best targets from the genome</article-title><source>Curr Opin Biotechnol</source><year>2001</year><volume>12</volume><fpage>626</fpage><lpage>631</lpage><pub-id pub-id-type="pmid">11849946</pub-id></element-citation></ref><ref id="CR130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinstein</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Deng</surname><given-names>C</given-names></name></person-group><article-title>Functions of mammalian Smad genes as revealed by targeted gene disruption in mice</article-title><source>Cytokine Growth Factor Rev</source><year>2000</year><volume>11</volume><fpage>49</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">10708952</pub-id></element-citation></ref><ref id="CR131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>RW</given-names></name><name><surname>Flaherty</surname><given-names>L</given-names></name><name><surname>Threadgill</surname><given-names>DW</given-names></name></person-group><article-title>The math of making mutant mice</article-title><source>Genes Brain Behav</source><year>2003</year><volume>2</volume><fpage>191</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">12953785</pub-id></element-citation></ref><ref id="CR132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>JI</given-names></name><name><surname>Reed</surname><given-names>RB</given-names></name><name><surname>Grabowski</surname><given-names>PJ</given-names></name><name><surname>Artzt</surname><given-names>K</given-names></name></person-group><article-title>Function of quaking in myelination: regulation of alternative splicing</article-title><source>Proc Natl Acad Sci U S A</source><year>2002</year><volume>99</volume><fpage>4233</fpage><lpage>4238</lpage><pub-id pub-id-type="pmid">11917126</pub-id></element-citation></ref><ref id="CR133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zambrowicz</surname><given-names>BP</given-names></name><name><surname>Sands</surname><given-names>AT</given-names></name></person-group><article-title>Knockouts model the 100 best-selling drugs&#x02014;will they model the next 100?</article-title><source>Nat Rev Drug Discov</source><year>2003</year><volume>2</volume><fpage>38</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">12509758</pub-id></element-citation></ref><ref id="CR134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zingg</surname><given-names>BC</given-names></name><name><surname>Pretsch</surname><given-names>W</given-names></name><name><surname>Mohrenweiser</surname><given-names>HW</given-names></name></person-group><article-title>Molecular analysis of four ENU induced triosephosphate isomerase null mutants in Mus musculus</article-title><source>Mutat Res</source><year>1995</year><volume>328</volume><fpage>163</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">7739600</pub-id></element-citation></ref></ref-list></back></article>
